Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — C44.01, C44.11, C44.21, C44.31, C44.41, C44.51, C44.61, C44.71, C44.81, C44.91 1 out of 7 registries used, show all original rules.	5900
4. Check minimum number of events None	5900
5. Include endpoints C3_BASAL_CELL_CARCINOMA_EXALLC	27710
6. Filter based on genotype QC (FinnGen only)	27710

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_BASAL_CELL_CARCINOMA_EXALLC
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	C44[0-9]1
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Basal cell carcinoma, including avohilmo

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	27710	13482	14228
Unadjusted period prevalence (%)	5.46	4.60	6.27
Median age at first event (years)	68.59	67.23	69.87

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11270: Matched controls
97316

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

115

Kela drug reimbursment

Breast cancer

+∞

323.0

638

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

+∞

323.0

4897

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

+∞

323.0

467

C61

ICD-10 Finland

Malignant neoplasm of prostate

358.6

323.0

594

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

323.0

359

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

323.0

364

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

+∞

323.0

383

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

323.0

552

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

323.0

1002

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

5383

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

+∞

323.0

1882

TQW99

NOMESCO Finland

Other minor procedure on skin

8.3

323.0

1103

1259

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

746.7

323.0

497

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

7.3

323.0

2393

3452

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1937.2

323.0

449

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

97.6

323.0

414

SPAT1153

SPAT

Removal of sutures

2.4

323.0

4463

20861

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

9.9

323.0

1684

1689

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

6.1

323.0

1368

2162

H02AB02

ATC

dexamethasone; systemic

18.2

323.0

756

383

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

+∞

323.0

822

ZZR00

NOMESCO Finland

Flap of skin

48.0

323.0

845

164

ZXC50

NOMESCO Finland

Cryotherapy

10.8

323.0

698

592

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

510

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

32.0

323.0

3927

1597

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

323.0

334

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

323.0

548

PJA12

NOMESCO Finland

Sentinel node biopsy

409.8

323.0

757

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

323.0

559

S77

ICPC

Malignant neoplasm of skin

134.1

323.0

390

S18

ICPC

Laceration/cut

2.5

323.0

5611

27809

L57.0

ICD-10 Finland

Actinic keratosis

9.1

323.0

2451

2868

R23.8

ICD-10 Finland

Other and unspecified skin changes

5.6

323.0

3574

7484

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

2918.6

323.0

337

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

323.0

1987

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

13.7

323.0

738

496

A04AA02

ATC

granisetron; systemic, transdermal

174.4

323.0

409

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

13.1

310.4

584

403

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

12.8

305.0

581

412

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

691.2

300.2

312

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

294.7

298

HAB40

NOMESCO Finland

Wedge excision of mammary gland

24.3

294.0

442

163

L02BG04

ATC

letrozole; oral

30.7

291.8

412

120

DHB00

NOMESCO Finland

Excision of lesion of external nose

48.6

280.9

360

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

412.8

266.2

281

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

579.8

251.8

263

L03AA13

ATC

pegfilgrastim; parenteral

457.9

247.1

260

WF002

NOMESCO Finland

Radical radiotherapy

49.0

246.3

315

116

Kela drug reimbursment

Prostate cancer

+∞

246.0

249

L82

ICD-10 Finland

Seborrhoeic keratosis

2.5

244.7

2354

9325

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

240.1

243

HAC20

NOMESCO Finland

Total mastectomy

166.0

237.4

263

WF003

NOMESCO Finland

Adjuvant radiotherapy

176.0

234.8

259

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1062.0

233.7

241

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

143.5

232.1

260

D06BB10

ATC

imiquimod; topical

5.3

231.7

770

1318

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

21.1

230.8

362

153

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

10.6

226.8

472

400

L02BA01

ATC

tamoxifen; oral

82.1

219.4

260

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

+∞

216.3

219

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

224.4

210.8

229

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

6.9

205.3

555

726

ZXC15

NOMESCO Finland

Use of photodynamic technique

19.6

201.4

323

146

JN4BD

NOMESCO Finland

Extensive body CT

4.0

196.1

878

2028

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

193.5

196

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

1664.7

193.2

198

L01BC06

ATC

capecitabine; oral

+∞

190.5

193

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

15.9

189.2

327

182

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

1584.7

184.3

189

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

183.6

186

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

1531.4

178.4

183

A03FA01

ATC

metoclopramide; systemic, rectal

2.5

177.2

1643

6265

A04AA55

ATC

palonosetron, combinations; systemic

1657.0

175.4

180

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

67.0

175.1

213

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

174.6

177

C50.99

ICD-10 Finland

Breast, unspecified

792.9

174.5

181

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

165.7

168

WF049

NOMESCO Finland

Radiotherapy of metastasis

498.2

162.9

171

L03AA02

ATC

filgrastim; parenteral

51.7

158.0

200

ZX090

NOMESCO Finland

Other technic of radiotherapy

94.4

157.1

183

HA1AA

NOMESCO Finland

X-ray mammography

4.5

156.2

611

1236

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

1434.4

154.7

159

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.1

153.6

522

909

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

355.0

153.5

163

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

149.9

152

S82

ICPC

Naevus/mole

2.3

149.0

1565

6316

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

4.0

145.9

640

1442

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

145.0

147

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

6.2

144.8

422

609

JN4AD

NOMESCO Finland

Body CT examination

4.2

144.0

595

1268

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

226.5

142.8

155

XX3DW

NOMESCO Finland

Time consuming IT work

3.4

142.6

758

2005

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

3.5

140.2

722

1862

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

140.0

142

S21

ICPC

Skin texture symptom/complaint

2.3

139.7

1536

6320

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

1248.8

136.9

141

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

24.9

135.2

201

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

135.1

137

A04AA01

ATC

ondansetron; systemic, rectal

4.8

133.3

478

882

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

131.1

133

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

129.2

131

S29

ICPC

Skin symptom/complaint other

2.0

128.9

1943

9139

XQ848

NOMESCO Finland

Dermatological photography

5.2

127.6

428

733

ZZA50

NOMESCO Finland

Full thickness skin graft

52.2

127.6

161

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

56.8

125.4

156

C50

ICD-10 Finland

Malignant neoplasm of breast

382.6

124.7

132

A04AD12

ATC

aprepitant; systemic

288.2

124.2

133

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

29.1

123.5

176

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

123.3

2942

16234

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

121.3

123

ZXC20

NOMESCO Finland

Use of chemical agents

8.1

120.9

291

318

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

6.1

119.2

348

503

ZZA00

NOMESCO Finland

Split skin graft

5.0

116.5

404

718

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

1046.1

116.3

120

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

522.1

114.5

120

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

114.3

116

NK6AN

NOMESCO Finland

Total body bone isotope imaging

23.8

113.7

171

XQ845

NOMESCO Finland

Dermatoscopy

9.2

112.1

250

240

Y77

ICPC

Malignant neoplasm prostate

154.6

111.5

124

ZX080

NOMESCO Finland

Image guided radiotherapy

207.6

109.2

119

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

4.4

108.4

421

842

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

108.4

110

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

4.3

108.1

439

917

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

12.3

107.9

207

148

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

+∞

107.4

109

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

117.3

106.4

121

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

39.4

105.4

140

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.7

104.4

380

711

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

104.3

386

735

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

64.8

103.3

126

CBB30

NOMESCO Finland

Excision of lesion of eyelid

3.8

100.7

457

1057

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

100.5

102

L03AA14

ATC

lipegfilgrastim; parenteral

887.6

98.5

102

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

+∞

96.6

L02BB03

ATC

bicalutamide; oral

861.2

95.6

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

93.6

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

12.8

93.0

175

120

X76

ICPC

Malignant neoplasm breast female

425.1

93.0

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

92.6

DAB00

NOMESCO Finland

Excision of lesion of auricle

13.2

92.4

171

113

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

826.0

91.7

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

91.6

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

91.6

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

148.0

91.5

102

Z51.5

ICD-10 Finland

Palliative care

6.2

91.0

263

375

D06BX02

ATC

ingenol mebutate; topical

7.5

90.3

227

266

C44

ICD-10 Finland

Other malignant neoplasms of skin

91.5

90.1

105

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

172.4

89.8

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

89.7

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

89.7

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

89.7

ZQZ00

NOMESCO Finland

Treatment of several skin areas

28.2

88.0

126

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

10.7

87.4

179

147

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

85.7

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

84.7

CBA10

NOMESCO Finland

Biopsy of eyelid

8.9

84.6

191

188

ZX070

NOMESCO Finland

Intensity modified radiotherapy

136.3

83.8

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

63.5

83.6

102

L02AE02

ATC

leuprorelin; implant, parenteral

9.9

83.3

177

156

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

82.7

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

17.0

82.5

138

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

729.5

80.9

WF004

NOMESCO Finland

Palliative radiotherapy

253.7

80.8

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

90.9

80.6

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

367.9

80.3

ZXC96

NOMESCO Finland

Robot assisted procedure

8.1

79.3

189

204

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

711.9

78.9

DAB10

NOMESCO Finland

Partial excision of auricle

99.0

78.8

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

2.8

78.2

557

1790

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

703.2

77.9

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

244.6

77.9

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

20.5

77.8

122

D22

ICD-10 Finland

Melanocytic naevi

2.9

76.3

495

1498

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

75.8

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

75.8

L02BG03

ATC

anastrozole; oral

39.6

75.6

100

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

676.9

75.0

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

74.9

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

341.5

74.4

S08

ICPC

Skin colour change

2.6

72.5

566

1920

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

650.6

72.0

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

71.9

S26

ICPC

Fear of cancer of skin

7.4

71.9

182

216

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

10.8

71.1

144

116

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

323.9

70.5

TQW20

NOMESCO Finland

Tatoe

51.0

69.8

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

68.9

WZC30

NOMESCO Finland

Teaching

1.9

68.1

1074

5043

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

67.5

2996

18869

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

3.9

67.3

294

657

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

67.2

2419

14516

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

211.4

67.2

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

67.0

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

66.0

L02BG06

ATC

exemestane; oral

+∞

66.0

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

19.0

65.5

105

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

65.0

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

126.8

64.8

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

20.4

64.5

101

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

91.9

63.7

JN4CD

NOMESCO Finland

Very extensive body CT

4.2

63.3

256

533

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

63.0

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

25.0

62.5

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

18.9

62.3

100

127

Kela drug reimbursment

Transplant complication

4.2

61.1

246

510

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

101.3

60.9

128

Kela drug reimbursment

Cancers of female genital organs

191.0

60.4

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

2.8

60.2

423

1346

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

60.1

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

60.1

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

536.9

59.3

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

528.1

58.3

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

510.6

56.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

56.1

1791

10376

XKD00

NOMESCO Finland

Uroflowmetry

1.7

56.0

1228

6414

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.8

55.0

384

1217

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

493.1

54.4

1733A

ICD-9 Finland

Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

54.2

C90.0

ICD-10 Finland

Multiple myeloma

248.5

53.0

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.8

52.7

188

346

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

52.2

B01AB05

ATC

enoxaparin; parenteral

1.5

51.8

2635

16892

C44.19

ICD-10 Finland

Malignant tumor of the skin of the eyelids including corner of the eye or other unspecified histology

+∞

51.2

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

123.6

50.6

ZX120

NOMESCO Finland

Intravenous

2.0

50.4

683

3014

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

50.2

Z51.0

ICD-10 Finland

Radiotherapy session

449.5

49.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

230.4

49.1

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

97.2

48.6

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

97.2

48.6

WF001

NOMESCO Finland

Preoperative radiotherapy

440.7

48.5

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.8

48.4

128

163

WX402

NOMESCO Finland

General anaesthesia

1.6

48.3

1347

7513

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

48.2

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

47.8

460

1743

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

4.0

47.8

203

444

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

15.0

47.8

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.9

47.4

304

913

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

47.3

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

47.3

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

47.3

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.1

47.2

564

2360

KC1GB

NOMESCO Finland

Cystography with X-ray

22.8

47.2

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

221.4

47.2

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

47.0

671

3017

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

10.7

47.0

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

38.4

46.9

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

46.3

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

+∞

46.3

ZXA00

NOMESCO Finland

Right side

1.4

46.2

2556

16593

A79

ICPC

Malignancy NOS

35.8

46.2

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

112.7

45.8

C82.1

ICD-10 Finland

Follicular lymphoma grade II

414.5

45.6

R4110

NOMESCO Finland

Physiotherapy

1.4

45.6

2386

15320

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

45.3

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

3.1

44.7

261

736

TQW40

NOMESCO Finland

Remowal of suture of skin

1.9

44.3

731

3470

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

208.0

44.3

KCD02

NOMESCO Finland

Transurethral resection of bladder

10.3

44.1

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.1

43.5

146

252

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

43.3

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

42.7

3936

27793

J01DB01

ATC

cefalexin; oral

1.4

42.6

8402

66433

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

42.1

991

5264

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.5

41.9

210

529

WW500

NOMESCO Finland

Blood transfusion

3.3

40.6

216

570

S79

ICPC

Neoplasm skin benign/unspecified

3.4

40.6

210

543

Z94.0

ICD-10 Finland

Kidney transplant status

4.0

40.4

173

382

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

40.4

ZZS00

NOMESCO Finland

Rotation flap

38.3

40.1

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

69.4

40.1

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

39.9

4001

28531

8097/3-C44.3

ICD-O-3

Basal cell carcinoma, nodular of skin of other and unspecified parts of face

+∞

39.4

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

39.4

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

39.4

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

39.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

68.0

39.2

QAE99

SPAT

6.0

38.6

112

163

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

38.4

1CD02

NOMESCO Finland

+∞

38.4

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

124.2

38.3

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

95.3

38.2

B01AB10

ATC

tinzaparin; parenteral

2.1

37.9

449

1872

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

344.7

37.8

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

344.7

37.8

ZXA05

NOMESCO Finland

Left side

1.4

37.4

2304

15158

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

56.9

37.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

37.4

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

93.2

37.3

N02AA05

ATC

oxycodone; systemic

1.7

36.9

849

4474

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

36.8

516

2305

L02BX02

ATC

degarelix; parenteral

+∞

36.4

L04AA06

ATC

mycophenolic acid; systemic

2.9

36.4

230

685

ZX112

NOMESCO Finland

Subcutaneous

4.8

36.4

127

230

UJF32

NOMESCO Finland

Coloscopy

1.4

36.0

2333

15471

J01MA02

ATC

ciprofloxacin; systemic

1.3

35.6

3552

25193

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

13.1

35.6

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

62.2

35.5

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

21.3

35.3

WX110

NOMESCO Finland

Local anesthesy

1.3

35.3

6630

51188

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

39.8

35.2

L04AD01

ATC

ciclosporin; systemic

2.8

34.9

237

741

TQW40

SPAT

2.2

34.8

357

1396

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

34.5

677

3398

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

34.4

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

86.6

34.4

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

2.9

34.0

216

645

WX002

NOMESCO Finland

Sedation and analgesia

1.4

34.0

1818

11634

ZZR10

NOMESCO Finland

Flap of skin and muscle

13.6

33.9

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

309.8

33.9

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

8.1

33.7

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

33.5

UKC02

NOMESCO Finland

Cystoscopy

1.5

33.4

1205

7117

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

45.5

33.0

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

301.0

32.9

XX1XN

NOMESCO Finland

Other isotope examination

301.0

32.9

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

32.8

270

944

JN6AD

NOMESCO Finland

CT of torso and neck

7.9

32.8

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

32.6

1578

9901

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

106.8

32.6

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

12.3

32.5

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

32.5

L01AX03

ATC

temozolomide; systemic

+∞

32.5

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.2

32.4

180

493

HAE99

NOMESCO Finland

Other reconstruction of breast

18.0

32.3

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

4.1

32.2

133

286

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

292.3

32.0

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.6

31.7

115

218

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.2

31.6

174

473

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.1

31.6

183

516

L04AA01

ATC

[U] ciclosporin; systemic

3.0

31.5

195

575

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

31.5

TQW80

NOMESCO Finland

Local dermatologic skincare

2.4

31.3

273

986

S15

ICPC

Foreign body in skin

1.8

31.1

593

2950

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

31.0

986

5649

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

64.2

30.7

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

30.5

1137

6753

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

30.5

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

30.5

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

30.5

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

30.5

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

30.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

30.5

E0000UV

ATC

1.3

30.4

3513

25288

R50.9

ICD-10 Finland

Fever, unspecified

1.6

30.1

947

5411

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

30.1

593

2978

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

274.8

30.0

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

19.9

29.6

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

7.9

29.5

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

29.5

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

29.5

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

270.5

29.1

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

270.5

29.1

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

60.7

28.9

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

138.5

28.8

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.7

28.8

133

316

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.8

28.7

128

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

28.5

C44.90

ICD-10 Finland

Unspecified localization of malignant tumor of the skin without histology

+∞

28.5

C44.00

ICD-10 Finland

Malignant tumor of the lip skin without histology

+∞

28.5

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

28.5

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

28.5

D70.82

ICD-10 Finland

Drug-induced neutropenia

6.6

28.5

100

G04CA02

ATC

tamsulosin; oral

1.4

28.5

1651

10687

L91.0

ICD-10 Finland

Hypertrophic scar

3.9

28.4

122

272

J05AB11

ATC

valaciclovir; oral

1.5

28.3

1121

6740

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

18.6

28.3

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

7.2

28.2

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

28.1

1076

6425

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

261.5

28.1

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

27.9

880

5026

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.6

27.6

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

27.6

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

27.6

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

27.6

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

27.6

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

24.7

27.5

N02BE01

ATC

paracetamol; systemic, rectal

1.3

27.5

8769

71051

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.6

27.4

130

316

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

27.3

2926

20787

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

12.7

27.2

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.8

27.2

121

279

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

26.9

216

745

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

89.5

26.9

KAC10

NOMESCO Finland

Total nephrectomy with capsule

16.6

26.7

L01CA04

ATC

vinorelbine; systemic

+∞

26.6

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

26.6

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

4.1

26.4

106

223

F16

ICPC

Eyelid symptom/complaint

1.9

26.3

425

1999

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

14.2

26.3

D23

ICD-10 Finland

Other benign neoplasms of skin

2.6

26.2

193

637

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

243.4

26.1

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

67.1

26.0

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

125.5

26.0

M05BX04

ATC

denosumab; parenteral

2.1

25.8

297

1224

D06BX01

ATC

metronidazole; topical

1.5

25.7

1002

6000

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

25.6

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

+∞

25.6

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

25.6

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

46.1

25.3

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.3

25.2

132

G04BE03

ATC

sildenafil; oral

5.0

25.2

143

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.5

25.1

122

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

24.9

2014

13719

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

12.5

24.9

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

14.3

24.7

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

24.6

424

2041

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

24.6

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

24.6

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

24.6

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

24.6

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

24.6

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

24.6

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.1

24.5

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.1

24.4

279

1149

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.8

24.3

161

499

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

51.9

24.2

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

225.4

24.2

D03.5

ICD-10 Finland

Melanoma in situ of trunk

9.8

24.1

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

24.0

1542

10133

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

23.7

1617

10723

XJH00

NOMESCO Finland

Transanal ultrasonography

1.9

23.7

370

1722

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

23.7

818

4769

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

23.6

8094/3-C44.9

ICD-O-3

Basosquamous carcinoma of skin, NOS

+∞

23.6

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

11.1

23.6

WW300

NOMESCO Finland

Transfer of autologic stem cells

43.3

23.5

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

6.8

23.5

A12AA04

ATC

calcium carbonate; oral

2.8

23.4

152

466

ZX095

NOMESCO Finland

Combined chemoradiotherapy

216.4

23.2

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

216.4

23.2

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.3

23.2

216

807

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

112.5

23.1

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

112.5

23.1

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

112.5

23.1

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

10.5

23.0

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

5.4

22.7

112

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

18.3

22.7

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

18.3

22.7

B07.9

ICD-10 Finland

Verruca simplex

2.0

22.7

282

1204

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

22.6

20199

ICD-8 Finland

Hodgkin's disease

+∞

22.6

R23

ICD-10 Finland

Other skin changes

3.2

22.5

121

326

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

18.9

22.3

C43

ICD-10 Finland

Malignant melanoma of skin

58.3

22.3

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

75.0

22.2

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

75.0

22.2

153

Kela drug reimbursment

Lenalidomid

75.0

22.2

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

108.1

22.1

9734

FHL

Excision and local plastic or associated free skin grafting

4.4

22.1

161

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

22.0

676

3832

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.6

22.0

162

535

QAE15

NOMESCO Finland

Excision of other superficial lesion of skin from head and neck

11.0

22.0

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

21.8

190

688

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.4

21.8

108

274

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

21.6

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

21.6

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

+∞

21.6

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

21.6

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

21.6

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

21.6

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.9

21.5

J05AB01

ATC

aciclovir; systemic

1.3

21.5

1782

12157

KEB00

NOMESCO Finland

Biopsy of prostate

5.5

21.5

102

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

198.9

21.3

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

5.2

21.3

114

L04AX04

ATC

lenalidomide; oral

103.8

21.2

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

3.5

20.8

100

248

J01MA12

ATC

levofloxacin; systemic

1.3

20.8

1442

9575

SPAT1325

SPAT

Vaccination

1.2

20.7

2856

20788

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

20.7

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

20.7

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

20.7

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

20.7

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

20.7

180

Kela drug reimbursment

Interferon alfa

+∞

20.7

L02BB04

ATC

enzalutamide; oral

+∞

20.7

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

+∞

20.7

C44.70

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including the hip without histology

+∞

20.7

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

16.3

20.7

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

20.6

182

663

WF090

NOMESCO Finland

Profylactic radiotherapy

69.3

20.3

QAE30

NOMESCO Finland

Excision and repair of surgical scar in head or neck

15.5

20.3

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

20.3

151

502

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

25.1

20.2

D23.4

ICD-10 Finland

Benign neoplasm: Skin of scalp and neck

3.3

20.0

104

274

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

2.8

19.9

129

394

A11CC03

ATC

alfacalcidol; systemic

2.3

19.9

189

717

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

3.8

19.8

196

SPAT1324

SPAT

Screening procedure

0.7

19.8

891

10343

A02BC02

ATC

pantoprazole; systemic

1.2

19.8

6278

49698

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

19.7

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

19.7

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

19.7

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

19.7

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

19.7

QAA99

NOMESCO Finland

Other local destruction of skin of head or neck

8.1

19.6

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

51.9

19.5

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

51.9

19.5

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

19.3

382

1924

TK800

NOMESCO Finland

Hemodialysis

2.2

19.2

192

745

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.0

19.1

115

336

B03XA01

ATC

erythropoietin; parenteral

4.1

19.0

157

B03XA02

ATC

darbepoetin alfa; parenteral

2.7

19.0

132

421

Z42.0

ICD-10 Finland

Follow-up care involving plastic surgery of head and neck

9.4

19.0

HA1HA

NOMESCO Finland

Tomosynthesis mammography

9.6

18.8

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

3.2

18.7

100

270

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

18.7

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

18.7

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

18.7

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

18.7

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

8.3

18.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

18.5

1005

6403

PJW99

NOMESCO Finland

Other operation on lymphatic system

63.5

18.4

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

172.9

18.4

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

172.9

18.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

172.9

18.4

R31

ICD-10 Finland

Unspecified haematuria

1.5

18.4

649

3800

EAA20

NOMESCO Finland

Partial excision of upper lip

90.8

18.4

S04

ICPC

Lump/swelling localized

1.5

18.2

727

4366

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

18.2

1913

13442

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

25.0

18.1

XX1AD

NOMESCO Finland

Other CT-examination

25.0

18.1

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.8

18.0

292

1379

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

18.0

347

1736

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

10.8

17.9

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

17.9

289

1363

JFB30

NOMESCO Finland

Right hemicolectomy

4.5

17.9

122

L02AE04

ATC

triptorelin; parenteral

18.6

17.9

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

17.9

2101

14963

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

39.8

17.9

L04AX01

ATC

azathioprine; systemic

1.7

17.8

380

1957

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

6.3

17.7

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

17.7

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

17.7

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

17.7

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

17.7

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

17.7

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

17.7

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

17.7

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.9

17.5

107

317

C44.5

ICD-10 Finland

Malignant neoplasm: Skin of trunk

60.6

17.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

17.3

2146

15377

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

33.1

17.2

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

17.1

649

3860

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

6.3

17.1

JG1BG

NOMESCO Finland

MRI of rectum

11.0

17.1

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

17.0

242

1092

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.8

17.0

166

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

38.0

17.0

D04.8

ICD-10 Finland

Carcinoma in situ: Skin of other sites

38.0

17.0

N18.0

ICD-10 Finland

End-stage renal disease

2.9

17.0

107

322

7151

FHL

Kidney transplantation

12.2

16.9

C44.1

ICD-10 Finland

Malignant neoplasm: Skin of eyelid, including canthus

+∞

16.7

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

16.7

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

16.7

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

16.7

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

16.7

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

16.7

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

+∞

16.7

8094/3-C44.3

ICD-O-3

Basosquamous carcinoma of skin of other and unspecified parts of face

+∞

16.7

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

16.7

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

16.7

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

16.7

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

16.7

C44.49

ICD-10 Finland

Malignant tumor of the skin of the scalp and of the neck other or unspecified histology

+∞

16.7

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

+∞

16.7

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

16.7

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

4.7

16.7

104

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

16.6

499

2814

ZX050

NOMESCO Finland

Stereotactic radiotherapy

11.1

16.6

QBE99

SPAT

3.8

16.6

161

PJA10

NOMESCO Finland

Exploration of lymph nodes

4.2

16.6

132

137

Kela drug reimbursment

Uraemia requiring dialysis

3.0

16.6

275

Z31.5

ICD-10 Finland

Genetic counselling

1.9

16.6

264

1240

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

16.5

348

1788

189

Kela drug reimbursment

Imatinib

155.6

16.5

EAA10

NOMESCO Finland

Excision of lesion of lip

2.8

16.4

109

340

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

5.3

16.3

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.4

16.2

142

518

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

11.2

16.2

SPAT1211

SPAT

Application of soft bandage

1.4

16.1

686

4177

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.9

16.0

229

1036

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

15.9

200

862

KE1BG

NOMESCO Finland

MRI of prostate

5.9

15.9

D75

ICPC

Malignant neoplasm colon/rectum

18.0

15.9

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.6

15.8

121

412

9650/3-C77.0

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck

+∞

15.7

HAC25

NOMESCO Finland

Radical mastectomy

+∞

15.7

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

+∞

15.7

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

+∞

15.7

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

15.7

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

15.7

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

15.7

390

Kela drug reimbursment

Ibrutinib

+∞

15.7

1XC02

NOMESCO Finland

4.4

15.7

115

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

6.1

15.6

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

22.1

15.6

KE1DG

NOMESCO Finland

Very extensive MRI of prostate

4.2

15.6

124

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.6

15.6

113

374

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

15.6

199

863

KDE20

NOMESCO Finland

Removal of foreign body from urethra

5.4

15.6

J01EA01

ATC

trimethoprim; systemic

1.2

15.5

1963

14074

K62.7

ICD-10 Finland

Radiation proctitis

146.9

15.5

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

146.9

15.5

JG1CG

NOMESCO Finland

Extensive MRI of rectum

10.8

15.5

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

7.4

15.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

15.4

154

602

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

15.4

633

3828

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.6

15.4

369

1966

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

15.3

170

695

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

15.3

452

2543

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.5

15.2

179

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

8.7

15.1

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

15.0

507

2939

KAD00

NOMESCO Finland

Partial nephrectomy

8.4

14.9

N63

ICD-10 Finland

Unspecified lump in breast

1.6

14.9

351

1865

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

2.4

14.8

130

477

1XC07

NOMESCO Finland

+∞

14.8

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

14.8

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

14.8

L01CB01

ATC

etoposide; systemic

+∞

14.8

1AA09

NOMESCO Finland

+∞

14.8

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

14.8

L01BB05

ATC

fludarabine; systemic

+∞

14.8

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

14.8

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

14.8

1512

Kela drug reimbursment

Ibrutinib

+∞

14.8

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

14.6

559

3332

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

138.3

14.6

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.9

14.6

276

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

14.5

1589

11195

JFF23

NOMESCO Finland

Transversostomy

5.2

14.4

TKE10

NOMESCO Finland

Puncture of prostate

22.7

14.4

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

10.5

14.3

G04BE01

ATC

alprostadil; parenteral, urethral

3.1

14.2

222

J01MA14

ATC

moxifloxacin; systemic

1.4

14.1

678

4224

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.4

14.1

100

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.6

14.1

243

3376

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

8.4

14.0

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

13.9

1937

14026

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

13.8

578

3510

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

13.8

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

13.8

L01XE01

ATC

[U] imatinib; oral

+∞

13.8

192

Kela drug reimbursment

Fulvestrant

+∞

13.8

C00.1

ICD-10 Finland

Malignant neoplasm: External lower lip

+∞

13.8

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

+∞

13.8

197

Kela drug reimbursment

Sunitinib

+∞

13.8

C44.4

ICD-10 Finland

Malignant neoplasm: Skin of scalp and neck

+∞

13.8

C44.12

ICD-10 Finland

Spinocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

13.8

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

+∞

13.8

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

13.8

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

13.8

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

13.8

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

13.8

WW402

NOMESCO Finland

Leucoferesis

+∞

13.8

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

13.8

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

13.8

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

13.8

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.0

13.7

172

744

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

69.2

13.6

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

69.2

13.6

KAC00

NOMESCO Finland

Nephrectomy

9.0

13.6

C44.69

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including shoulder other or unspecified histology

129.6

13.6

3AA13

NOMESCO Finland

129.6

13.6

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

129.6

13.6

-54

ICPC

Repair/fix-suture/cast/prosth device

1.9

13.6

192

869

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.1

13.4

215

D23.0

ICD-10 Finland

Benign neoplasm: Skin of lip

4.6

13.3

A07AA02

ATC

nystatin; oral

1.5

13.3

447

2589

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

23.5

13.2

C56

ICD-10 Finland

Malignant neoplasm of ovary

36.7

13.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

13.1

2443

18210

A06AH03

ATC

naloxegol; oral

4.8

13.0

L01BB01

ATC

6.4

12.9

QAA10

NOMESCO Finland

Incision of skin of head or neck

7.6

12.9

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

25.9

12.9

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

25.9

12.9

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

12.8

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

12.8

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

12.8

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

12.8

L01XE27

ATC

[U] ibrutinib; oral

+∞

12.8

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

12.8

L02BA03

ATC

fulvestrant; parenteral

+∞

12.8

L02BX03

ATC

abiraterone; oral

+∞

12.8

1501

Kela drug reimbursment

Palbociclib

+∞

12.8

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

12.8

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

12.8

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

12.8

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

+∞

12.8

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

12.8

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

12.8

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

12.8

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

12.8

JAL30

NOMESCO Finland

Omentectomy

4.2

12.8

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

6.3

12.7

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

10.3

12.7

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

64.9

12.7

WW409

NOMESCO Finland

Other aferesis

20.5

12.7

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.3

12.7

116

436

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

4.1

12.7

103

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

7.1

12.7

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

121.0

12.6

9706

FHL

Ablation mammae, includes axillary exploration

121.0

12.6

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

121.0

12.6

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

121.0

12.6

D01AE16

ATC

amorolfine; topical

1.3

12.6

1019

6896

TQB05

NOMESCO Finland

Puncture of skin of trunk

4.7

12.6

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

5.0

12.5

D04.0

ICD-10 Finland

Carcinoma in situ: Skin of lip

29.4

12.5

ZZS10

NOMESCO Finland

Transposition flap

29.4

12.5

A06AD11

ATC

lactulose; oral

1.3

12.5

897

5971

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.4

12.5

545

3335

G04CB02

ATC

dutasteride; oral

1.5

12.5

380

2156

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.0

12.4

153

655

TJF80

NOMESCO Finland

Ostomy education

4.6

12.4

R23.4

ICD-10 Finland

Changes in skin texture

2.6

12.4

294

S52

ICPC

Skin, Exc/remov/biopsy/destruc/debrid/caut

5.7

12.3

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

34.5

12.2

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.9

12.2

231

S19

ICPC

Skin injury other

1.7

12.2

271

1418

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.7

12.2

262

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

12.2

4513

35578

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

2.8

12.2

245

329

Kela drug reimbursment

Lenalidomide

43.2

12.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

11.9

2851

21702

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

5.3

11.8

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

4.8

11.8

8720/3-C44.3

ICD-O-3

Malignant melanoma, NOS, of skin of other and unspecified parts of face

+∞

11.8

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

11.8

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

11.8

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

+∞

11.8

C44.82

ICD-10 Finland

Overall spinocellular carcinoma of the skin

+∞

11.8

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

11.8

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

+∞

11.8

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

11.8

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

11.8

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

11.8

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

+∞

11.8

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

11.8

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

11.8

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

11.8

L57.9

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation, unspecified

7.8

11.8

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

7.0

11.8

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

60.6

11.8

C44.9

ICD-10 Finland

Malignant neoplasm: Malignant neoplasm of skin, unspecified

60.6

11.8

-59

ICPC

Other therap proced/minor surg NEC

1.8

11.8

202

979

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

11.8

495

3010

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

112.3

11.7

KE1DR

NOMESCO Finland

Prostate metabolic PET with CT

112.3

11.7

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

112.3

11.7

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

3.4

11.7

147

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

11.6

579

3634

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

2.8

11.6

225

H26.4

ICD-10 Finland

After-cataract

1.4

11.5

528

3264

L72.1

ICD-10 Finland

Trichilemmal cyst

1.4

11.5

496

3030

WXQ99

NOMESCO Finland

Other light therapy

13.3

11.5

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

6.1

11.5

D48

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other and unspecified sites

6.9

11.4

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

9.5

11.3

V03AE02

ATC

sevelamer; oral

3.4

11.3

142

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

11.2

320

1790

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

3.4

11.2

134

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.4

11.2

577

3646

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

8.0

11.2

WF099

NOMESCO Finland

Other radiotherapy

6.7

11.2

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

23.0

11.1

A04AA03

ATC

tropisetron; systemic

23.0

11.1

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

3.8

11.1

108

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

40.3

11.1

ZXA10

NOMESCO Finland

Bilateral

1.2

11.1

1397

9988

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

18.4

11.1

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

1.9

11.0

165

763

H91.1

ICD-10 Finland

Presbycusis

1.6

11.0

277

1502

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.7

10.9

305

3839

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.1

10.9

128

540

G04CA01

ATC

alfuzosin; oral

1.3

10.9

835

5609

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.4

10.9

128

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

10.8

1523

Kela drug reimbursment

+∞

10.8

3054

Kela drug reimbursment

+∞

10.8

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

10.8

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

10.8

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

10.8

316

Kela drug reimbursment

Imatinib

+∞

10.8

394

Kela drug reimbursment

Palbociclib

+∞

10.8

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

10.8

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

10.8

17331

ICD-8 Finland

Other malignant neoplasm of skin, Other and unspecified part of face

+∞

10.8

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

10.8

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

10.8

8090/3-C44.8

ICD-O-3

Basal cell carcinoma, NOS, of overlapping lesion of skin

+∞

10.8

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

+∞

10.8

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

10.8

QA6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in cheeks or nose

+∞

10.8

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

10.8

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

10.8

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

+∞

10.8

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

10.8

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

10.8

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

10.8

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

10.8

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

10.8

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

10.8

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

10.8

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

10.8

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.9

10.8

J01FA10

ATC

azithromycin; systemic

1.1

10.7

5426

43588

X77

ICPC

Malignant neopl genital female other

103.7

10.7

1XC03

NOMESCO Finland

103.7

10.7

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

103.7

10.7

N02AX02

ATC

tramadol; systemic, rectal

1.2

10.6

3806

29837

QBA10

NOMESCO Finland

Incision of skin of trunk

2.6

10.6

263

L21.0

ICD-10 Finland

Seborrhoea capitis

2.5

10.6

294

A59

ICPC

General and Unspecified, Other therap proced/minor surg NEC

2.7

10.6

228

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.5

10.5

314

1774

WW200

NOMESCO Finland

Immunization

1.8

10.5

178

863

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.6

10.5

247

1318

L03AB05

ATC

interferon alfa-2b; parenteral

5.0

10.5

S59

ICPC

Skin, Other therap proced/minor surg NEC

2.2

10.5

103

402

ZX108

NOMESCO Finland

Inhalation

3.1

10.4

156

L01AA02

ATC

chlorambucil; oral

11.7

10.4

B05DA

ATC

Isotonic solutions

2.7

10.4

219

D03.7

ICD-10 Finland

Melanoma in situ of lower limb, including hip

8.6

10.3

ZZT00

NOMESCO Finland

Local skin and subcutaneous tissue flap

21.6

10.3

RS220

NOMESCO Finland

2.5

10.3

288

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

14.7

10.2

M04AA01

ATC

allopurinol; systemic

1.3

10.2

857

5830

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.7

10.2

214

1104

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

37.4

10.2

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

9.1

10.1

GDC00

NOMESCO Finland

Lobectomy of lung

8.3

10.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.4

10.1

294

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

3.4

10.0

123

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

10.0

164

786

N05CF01

ATC

zopiclone; oral

1.2

10.0

2662

20389

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

3.1

10.0

147

A12BA01

ATC

potassium chloride; oral

1.6

10.0

261

1432

C44.92

ICD-10 Finland

Unspecified localization of spinocellular carcinoma of the skin

51.8

9.9

D76

ICPC

Malignant neoplasm pancreas

51.8

9.9

S80

ICPC

Solar keratosis/sunburn

5.5

9.9

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

9.9

912

6281

205

Kela drug reimbursment

Chronic hypertension

1.2

9.8

2337

17729

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

9.8

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

9.8

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

9.8

8742/3-C44.9

ICD-O-3

Lentigo maligna melanoma of skin, NOS

+∞

9.8

8070/3-C09.9

ICD-O-3

Squamous cell carcinoma, NOS, of tonsil, NOS

+∞

9.8

L01EA01

ATC

imatinib; oral (bcr-abl tyrosine kinase inhibitors)

+∞

9.8

XX9CD

NOMESCO Finland

Very extensive complementary CT

+∞

9.8

8720/3-C44.4

ICD-O-3

Malignant melanoma, NOS, of skin of scalp and neck

+∞

9.8

L01EL01

ATC

ibrutinib; oral

+∞

9.8

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

9.8

4CJ01

NOMESCO Finland

+∞

9.8

L04AX06

ATC

pomalidomide; oral

+∞

9.8

9061/3-C62.9

ICD-O-3

Seminoma, NOS, of testis, NOS

+∞

9.8

9863/3-C42.1

ICD-O-3

Chronic myeloid leukemia, NOS, of bone marrow

+∞

9.8

L01XE23

ATC

[U] dabrafenib; oral

+∞

9.8

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

+∞

9.8

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

9.8

C09.0

ICD-10 Finland

Malignant neoplasm: Tonsillar fossa

+∞

9.8

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

9.8

C81.2

ICD-10 Finland

Mixed cellularity classical Hodgkin lymphoma

+∞

9.8

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

9.8

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

9.8

393

Kela drug reimbursment

Pomalidomide

+∞

9.8

C43.40

ICD-10 Finland

Malignant melanoma of the scalp and neck without histology

+∞

9.8

EBA00

NOMESCO Finland

Extraction of tooth

0.9

9.8

2197

21500

HA1SA

NOMESCO Finland

Expansion mammography

10.3

9.8

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

95.0

9.8

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

95.0

9.8

CBD11

NOMESCO Finland

Opening of eylid graft or flap

95.0

9.8

Z71.8

ICD-10 Finland

Other specified counselling

1.2

9.8

1773

13135

SPAT1312

SPAT

General health counselling

1.2

9.8

2643

20257

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

9.7

452

2804

QAE35

NOMESCO Finland

Repair of skin defect in head or neck after surgery or injury

11.1

9.7

H02AB04

ATC

methylprednisolone; systemic

1.2

9.7

1256

9002

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

3.5

9.6

109

D23.6

ICD-10 Finland

Benign neoplasm: Skin of upper limb, including shoulder

2.7

9.6

205

D18.0

ICD-10 Finland

Haemangioma, any site

1.8

9.5

171

847

L57.8

ICD-10 Finland

Other skin changes due to chronic exposure to nonionizing radiation

4.5

9.5

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

9.5

106

440

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.4

9.5

275

SPAT1361

SPAT

Collection of tissue sample

3.2

9.4

134

D03.6

ICD-10 Finland

Melanoma in situ of upper limb, including shoulder

6.5

9.4

D04

ICD-10 Finland

Carcinoma in situ of skin

16.2

9.4

D05.0

ICD-10 Finland

Lobular carcinoma in situ

16.2

9.4

A02BC05

ATC

esomeprazole; systemic

1.1

9.4

3795

29930

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.1

9.4

104

432

ZZG00

NOMESCO Finland

Graft of cartilage

10.4

9.4

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

5.3

9.4

M05BA04

ATC

alendronic acid; oral

1.4

9.4

547

3530

CBB99

NOMESCO Finland

Other excision or destruction of lesion of eyelid

3.7

9.4

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.7

9.3

189

N05AX08

ATC

risperidone; systemic

0.7

9.2

239

3048

WW200

SPAT

0.8

9.2

560

6244

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

9.2

168

835

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

9.2

2366

18057

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.0

9.1

119

527

ZX100

NOMESCO Finland

Oral

2.3

9.1

294

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

9.7

9.1

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.5

9.1

282

1615

J02AC01

ATC

fluconazole; systemic

1.1

9.0

3541

27853

75310

ICD-8 Finland

Congenital anomalies of urinary system, Ren polycysticus bilateralis

17.3

9.0

HA1DA

NOMESCO Finland

Restricted mammography

17.3

9.0

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

47.5

9.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

9.0

328

1946

R4190

NOMESCO Finland

Nutritional therapy

1.7

8.9

164

818

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.7

8.9

169

851

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

8.9

4506

36038

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

5.4

8.9

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

8.9

3012

Kela drug reimbursment

Cabozantinib

+∞

8.9

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

+∞

8.9

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

8.9

C81.0

ICD-10 Finland

Nodular lymphocyte predominant Hodgkin lymphoma

+∞

8.9

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

8.9

L01XE04

ATC

[U] sunitinib; oral

+∞

8.9

C43.42

ICD-10 Finland

Malignant melanoma of the scalp and neck: 'superficial spreading' type

+∞

8.9

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

+∞

8.9

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

8.9

EJB40

NOMESCO Finland

Hemiglossectomy

+∞

8.9

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

8.9

159

Kela drug reimbursment

Pazopanib

+∞

8.9

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

8.9

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

8.9

198

Kela drug reimbursment

Sorafenib

+∞

8.9

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

+∞

8.9

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

8.9

8091/3-C44.5

ICD-O-3

Superficial basal cell carcinoma of skin of trunk

+∞

8.9

8317/3-C64.9

ICD-O-3

Renal cell carcinoma, chromophobe type of kidney, NOS

+∞

8.9

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

8.9

1507

Kela drug reimbursment

Pomalidomide

+∞

8.9

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

8.9

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

8.9

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

8.9

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

8.9

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

8.9

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

+∞

8.9

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

8.9

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

8.9

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

8.9

L01EF01

ATC

palbociclib; oral

+∞

8.9

8092/3-C44.9

ICD-O-3

Infiltrating basal cell carcinoma, NOS, of skin, NOS

+∞

8.9

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

8.9

1731A

ICD-9 Finland

Other malignant neoplasm of skin, Eyelid, including canthus[LUOMEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

8.9

1502

Kela drug reimbursment

Cabozantinib

+∞

8.9

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

8.9

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

86.4

8.8

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

86.4

8.8

58200

ICD-8 Finland

Chronic nephritis, Cum uraemia

8.2

8.8

QXE99

NOMESCO Finland

Other excision or repair of unspecified region of skin

8.2

8.8

B05DB

ATC

Hypertonic solutions

2.8

8.7

170

A10BA02

ATC

metformin; oral

0.9

8.7

1919

18828

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.0

8.7

146

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

8.7

727

4944

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.5

8.7

235

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.8

8.7

141

676

S27

ICPC

Fear of skin disease other

3.0

8.6

134

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

8.6

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

3.7

8.6

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.4

8.5

248

Y06

ICPC

Prostate symptom/complaint

1.7

8.5

167

847

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

10.6

8.5

H81

ICPC

Excessive ear wax

1.2

8.5

1195

8635

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.4

8.5

858

C02EA02

ATC

1.5

8.4

265

1521

L71.9

ICD-10 Finland

Rosacea, unspecified

1.7

8.4

173

893

N18.8

ICD-10 Finland

Other chronic renal failure

1.7

8.4

162

819

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

11.8

8.4

L04AA10

ATC

sirolimus; oral

11.8

8.4

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.5

8.4

1121

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

1.7

8.3

153

762

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.6

8.3

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.3

8.3

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

3.7

8.3

V03AE01

ATC

polystyrene sulfonate; oral

2.3

8.3

291

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

8.3

1172

8472

D23.7

ICD-10 Finland

Benign neoplasm: Skin of lower limb, including hip

2.3

8.3

284

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

20.7

8.2

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

8.2

176

920

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

8.2

1454

10744

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.6

8.2

221

1226

C08CA01

ATC

amlodipine; oral

1.1

8.1

3085

24176

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.1

8.1

335

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

43.2

8.1

KE1CG

NOMESCO Finland

Extensive MRI of prostate

4.8

8.1

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.1

8.1

L85.89

ICD-10 Finland

Other specified epidermal thickening

4.1

8.1

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

10.8

8.1

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

10.8

8.1

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

5.8

8.0

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.3

8.0

523

3437

H26.3

ICD-10 Finland

Drug-induced cataract

2.5

8.0

202

L73.8

ICD-10 Finland

Other specified follicular disorders

2.4

8.0

235

J01AA04

ATC

lymecycline; systemic

1.2

8.0

958

6806

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

4.7

7.9

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.3

7.9

OAB42

NOMESCO Finland

Guidance related to known health problem

6.4

7.9

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

77.8

7.9

WXQ40

NOMESCO Finland

Photodynamic therapy of broad area

77.8

7.9

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

77.8

7.9

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

77.8

7.9

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

77.8

7.9

KAC20

NOMESCO Finland

Nephroureterectomy

77.8

7.9

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

77.8

7.9

HAD40

NOMESCO Finland

Mastopexy

5.1

7.9

20298

ICD-8 Finland

Other neoplasms of lymphoid tissue, Lymphomata alia

+∞

7.9

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

7.9

C96.9

ICD-10 Finland

Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified

+∞

7.9

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

7.9

C43.33

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face nodular

+∞

7.9

QCA30

NOMESCO Finland

Electrocoagulation of skin of upper limb

+∞

7.9

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

7.9

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

7.9

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

7.9

8520/3-C50.1

ICD-O-3

Lobular carcinoma, NOS, of central portion of breast

+∞

7.9

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

7.9

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

7.9

L01BC59

ATC

trifluridine, combinations; systemic

+∞

7.9

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

+∞

7.9

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

7.9

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

7.9

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

7.9

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

7.9

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

7.9

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

7.9

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

7.9

C43.00

ICD-10 Finland

Malignant melanoma of the lip without histology

+∞

7.9

C16.00

ICD-10 Finland

Cardia

+∞

7.9

8097/3-C44.4

ICD-O-3

Basal cell carcinoma, nodular of skin of scalp and neck

+∞

7.9

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

7.9

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

7.9

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

7.9

C43.82

ICD-10 Finland

Overall malignant melanoma of the skin: 'superficial spreading' type

+∞

7.9

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

7.9

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

7.9

8097/3-C44.5

ICD-O-3

Basal cell carcinoma, nodular of skin of trunk

+∞

7.9

ZZS55

NOMESCO Finland

Distension of tissue expander

+∞

7.9

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

7.9

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

7.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.1

7.9

3701

29397

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

3.3

7.9

100

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.4

7.8

340

2090

Z10.0

ICD-10 Finland

Occupational health examination

0.7

7.8

179

2332

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

10.0

7.8

C03CA01

ATC

furosemide; systemic

1.2

7.7

1797

13582

HAD99

NOMESCO Finland

Other plastic operation on breast

4.5

7.7

L04AA05

ATC

[U] tacrolimus; systemic

6.6

7.7

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

3.2

7.7

102

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

5.7

7.6

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.3

7.6

638

4344

WX892

NOMESCO Finland

Monitored bed care

1.3

7.6

478

3127

H02

ICPC

Hearing complaint

1.2

7.6

866

6120

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.3

7.6

501

3301

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.5

7.5

240

1384

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

4.1

7.5

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

7.5

1184

8646

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

2.7

7.5

157

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

7.5

1492

11128

103

Kela drug reimbursment

Diabetes, insulin-treated

0.9

7.5

1844

17968

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.8

7.5

129

630

D77

ICPC

Malignant digestive neopl other/NOS

28.8

7.5

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

28.8

7.5

EAA30

NOMESCO Finland

Partial excision of lower lip

28.8

7.5

L85.3

ICD-10 Finland

Xerosis cutis

2.3

7.5

261

Z93.2

ICD-10 Finland

Ileostomy status

4.2

7.4

ICD-10 Finland

1.6

7.4

181

979

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.9

7.4

1736

16972

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

2.8

7.4

147

N07BB01

ATC

disulfiram; oral

0.6

7.4

154

2044

ZXC10

NOMESCO Finland

Use of laser

1.7

7.4

158

827

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.4

7.4

392

2494

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

5.1

7.4

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

3.2

7.4

A98

ICPC

Health maint/preventive medicine

1.2

7.3

10476

88981

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.0

7.3

L01AA01

ATC

cyclophosphamide; systemic

4.1

7.3

QCE99

SPAT

4.4

7.3

P15

ICPC

Chronic alcohol abuse

0.5

7.3

1175

S99

ICPC

Skin disease other

1.8

7.2

127

627

SPAT1002

SPAT

Excision or drainage of chalazion

2.2

7.2

293

8742/2-C44.9

ICD-O-3

Lentigo maligna of skin, NOS

7.7

7.2

4194

NOMESCO Finland

38.9

7.2

Z94.4

ICD-10 Finland

Liver transplant status

3.4

7.2

SPAT1193

SPAT

Pap smear

0.7

7.2

312

3640

C08CA02

ATC

felodipine; oral

1.3

7.2

662

4563

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

4.0

7.2

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

4.0

7.2

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

0.3

7.2

425

X21

ICPC

Breast sympt/compl female other

1.9

7.1

414

D07AC01

ATC

betamethasone; topical

1.1

7.1

2993

23575

Z94.1

ICD-10 Finland

Heart transplant status

3.8

7.1

H13

ICPC

Plugged feeling ear

1.2

7.0

1366

10166

1CX01

NOMESCO Finland

6.2

7.0

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.4

7.0

393

2524

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.5

7.0

251

1485

C07AB03

ATC

atenolol; systemic

1.4

7.0

377

2405

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

2.7

7.0

143

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

15.8

7.0

QAA05

SPAT

7.3

7.0

JJB71

NOMESCO Finland

Laparoscopic resection of liver

69.2

7.0

N30.4

ICD-10 Finland

Irradiation cystitis

69.2

7.0

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

69.2

7.0

1CD01

NOMESCO Finland

69.2

7.0

H02.1

ICD-10 Finland

Ectropion of eyelid

2.7

7.0

144

Z00.0

ICD-10 Finland

General medical examination

1.2

7.0

1403

10478

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

+∞

6.9

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

+∞

6.9

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

+∞

6.9

KDK10

NOMESCO Finland

Implantation of artificial urinary sphincter around bulbar urethra

+∞

6.9

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

6.9

LE090

NOMESCO Finland

Profylactive radiotherapy of vulva and vagina

+∞

6.9

8743/3-C44.6

ICD-O-3

Low cumulative sun damage melanoma of skin of upper limb and shoulder

+∞

6.9

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

6.9

C44.79

ICD-10 Finland

Malignant tumor of the skin of the lower extremity including hip or other unspecified histology

+∞

6.9

8093/3-C44.9

ICD-O-3

Basal cell carcinoma, fibroepithelial of skin, NOS

+∞

6.9

L01XX28

ATC

[D] imatinib; oral

+∞

6.9

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

6.9

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

6.9

L01EX07

ATC

cabozantinib; oral

+∞

6.9

8070/3-C02.9

ICD-O-3

Squamous cell carcinoma, NOS, of tongue, NOS

+∞

6.9

8480/3-C50.4

ICD-O-3

Mucinous adenocarcinoma of upper-outer quadrant of breast

+∞

6.9

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

+∞

6.9

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

6.9

L01BC53

ATC

tegafur, combinations; systemic

+∞

6.9

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

6.9

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

+∞

6.9

9650/3-C77.1

ICD-O-3

Hodgkin lymphoma, NOS, of intrathoracic lymph nodes

+∞

6.9

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

+∞

6.9

L01XX52

ATC

venetoclax; oral

+∞

6.9

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

6.9

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

+∞

6.9

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

6.9

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

6.9

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

6.9

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

+∞

6.9

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

6.9

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

6.9

399

Kela drug reimbursment

Venetoclax

+∞

6.9

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

6.9

C84.51

ICD-10 Finland

Other and unspecified T-cell lymphomas

+∞

6.9

U75

ICPC

Malignant neoplasm of kidney

+∞

6.9

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

6.9

322

Kela drug reimbursment

Sunitinib

+∞

6.9

C45.0

ICD-10 Finland

Mesothelioma of pleura

+∞

6.9

C62.11

ICD-10 Finland

Malignant tumor of the descending testicle, seminoma

+∞

6.9

C739

ICD-10 Finland

+∞

6.9

L01XE25

ATC

[U] trametinib; oral

+∞

6.9

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

6.9

WB221

NOMESCO Finland

Demanding neoadjuvant hormone therapy of malignancy

+∞

6.9

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

+∞

6.9

JN4LR

NOMESCO Finland

Extensive PET-CT of receptors in whole body

+∞

6.9

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

1.8

6.9

105

496

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

6.9

388

2497

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

2.5

6.9

167

G03CA04

ATC

estriol; systemic, vaginal

1.4

6.8

381

2448

N05AA02

ATC

levomepromazine; systemic

0.7

6.8

161

2086

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.4

6.8

324

2029

HA1BA

NOMESCO Finland

Extensive X-ray mammography

3.2

6.8

Z01.2

ICD-10 Finland

Dental examination

1.1

6.8

3568

28475

4056

NOMESCO Finland

7.6

6.8

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

7.6

6.8

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

1.9

6.7

431

Z93.3

ICD-10 Finland

Colostomy status

3.5

6.7

XQ902

NOMESCO Finland

Other photography

2.7

6.7

136

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

6.7

1442

10833

XCD10

NOMESCO Finland

Electrophysiological examination of eye

1.7

6.7

144

757

A97

ICPC

No disease

1.2

6.7

1036

7560

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

6.7

615

4241

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

2.2

6.7

231

J01MA06

ATC

norfloxacin; oral

1.2

6.7

1066

7801

KCC10

NOMESCO Finland

Cystoprostatectomy

25.9

6.6

G04BE30

ATC

drugs used in erectile dysfunction - combinations

25.9

6.6

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

6.6

849

6077

C02CA01

ATC

prazosin; oral

1.9

6.6

391

R01AD09

ATC

mometasone; nasal

1.1

6.6

4030

32413

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.2

6.6

811

5781

H00.00

ICD-10 Finland

Hordeolum

1.4

6.6

260

1573

XCK10

NOMESCO Finland

Photography of fundus of eye

1.2

6.6

718

5053

H75

ICPC

Neoplasm of ear

17.3

6.6

M05BA02

ATC

clodronic acid; systemic

17.3

6.6

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

6.6

5511

45081

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

4.9

6.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.7

6.5

119

597

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

2.7

6.5

140

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.9

6.5

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

6.5

1303

9721

KFC00

NOMESCO Finland

Unilateral orchiectomy

4.1

6.5

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

6.5

1271

9464

BAA60

NOMESCO Finland

Total thyroidectomy

1.7

6.5

136

711

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

6.5

1466

11048

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.3

6.5

489

3287

H00.1

ICD-10 Finland

Chalazion

1.5

6.5

243

1455

G04BD12

ATC

mirabegron; oral

1.2

6.5

706

4966

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

1.8

6.5

451

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

3.2

6.5

H61.2

ICD-10 Finland

Impacted cerumen

1.3

6.5

383

2484

L72.0

ICD-10 Finland

Epidermal cyst

2.0

6.5

333

X26

ICPC

Fear of breast cancer female

3.0

6.4

L21

ICD-10 Finland

Seborrhoeic dermatitis

1.8

6.4

470

D01BA02

ATC

terbinafine; oral; topical

1.1

6.4

2259

17577

R60.0

ICD-10 Finland

Localized oedema

1.2

6.4

720

5085

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.2

6.4

758

5384

C10AA04

ATC

fluvastatin; oral

1.3

6.4

601

4155

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

6.4

387

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

1.5

6.4

193

1106

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

8.6

6.3

P72

ICPC

Schizophrenia

0.5

6.3

687

5702

FHL

Local lymph node removal (eg armpit, groin)

7.6

6.3

QAB05

NOMESCO Finland

Revision of wound of skin of head or neck

3.8

6.3

A41.9

ICD-10 Finland

Sepsis, unspecified

1.5

6.3

174

975

ZZS40

NOMESCO Finland

V-Y or Y-V advancement flap

34.5

6.3

T71

ICPC

Malignant neoplasm thyroid

34.5

6.3

D03.30

ICD-10 Finland

Melanoma in situ on the lip

34.5

6.3

J94.8

ICD-10 Finland

Other specified pleural conditions

2.1

6.3

278

H04.10

ICD-10 Finland

Dry eye syndrome

1.2

6.3

764

5441

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

1.7

6.3

130

677

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.0

6.3

321

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.6

6.3

145

779

J01AA02

ATC

doxycycline; systemic

1.1

6.3

7988

66708

UDC00

NOMESCO Finland

Ear microscopy

1.3

6.2

503

3412

N04AA02

ATC

biperiden; systemic

0.5

6.2

877

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

6.2

162

894

N64.5

ICD-10 Finland

Other signs and symptoms in breast

1.7

6.2

128

667

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

6.2

1524

11561

N05CB02

ATC

barbiturates in combination with other drugs

1.6

6.2

144

773

N05AH03

ATC

olanzapine; systemic

0.7

6.2

207

2515

JJB10

NOMESCO Finland

Atypcal resection of liver

19.4

6.2

Q61.1

ICD-10 Finland

Polycystic kidney, autosomal recessive

19.4

6.2

KFC10

NOMESCO Finland

Bilateral orchiectomy

19.4

6.2

1XX32

NOMESCO Finland

19.4

6.2

J01MA01

ATC

ofloxacin; systemic

1.3

6.2

620

4324

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.2

6.2

234

F10.25

ICD-10 Finland

Alcohol dependence continuous use

0.5

6.2

742

A10BK03

ATC

empagliflozin; oral

0.8

6.2

408

4494

Z43.3

ICD-10 Finland

Attention to colostomy

9.4

6.2

K03.64

ICD-10 Finland

Dental calculus supragingival

1.1

6.1

2225

17337

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

4.8

6.1

N64.9

ICD-10 Finland

Disorder of breast, unspecified

2.2

6.1

217

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

4.1

6.1

JAB00

NOMESCO Finland

Division and ligature of inguinal hernia sac

5.4

6.1

QBE10

SPAT

3.7

6.1

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

2.4

6.1

168

KED22

NOMESCO Finland

Transurethral resection of prostate

1.4

6.1

249

1519

JAH00

NOMESCO Finland

Laparotomy

1.7

6.1

128

670

L60.8

ICD-10 Finland

Other nail disorders

2.1

6.1

259

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

2.8

6.1

111

7125

FHL

Nephrectomy (extrrafascial)

60.6

6.0

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

60.6

6.0

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

60.6

6.0

C44.7

ICD-10 Finland

Malignant neoplasm: Skin of lower limb, including hip

60.6

6.0

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

60.6

6.0

D18

ICPC

Change in faeces/bowel movements

1.7

6.0

124

645

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

15476

42444

5.22

307.65

3.3

1.7

—

(4035726)

2675

3879

5.21

307.65

1.4

1.2

—

(3002256) Pathology report gross observation

7600

10262

6.98

307.65

1.6

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2724

7456

2.71

307.65

3.7

1.5

ug/l

13.3

8.7

0.82

2219

5635

(40768443) Skin Pathology biopsy report

2216

5475

2.97

307.65

1.3

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

373

209

12.45

302.86

2.6

1.1

u/ml

28.3

29.2

0.03

360

191

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

12058

63593

1.61

261.50

6.2

3.8

umol/l

12.1

11.9

0.78

11338

59306

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

17321

100099

1.68

257.67

8.1

5.5

u/l

79.9

76.3

14.73

16100

92252

(3024561) Albumin [Mass/volume] in Serum or Plasma

10725

55416

1.60

248.55

5.0

3.8

g/l

34.9

35.5

23.53

9799

50411

(3015377) Calcium [Moles/volume] in Serum or Plasma

8512

41730

1.62

243.40

3.4

2.1

mmol/l

2.4

0.43

7185

34488

(3013650) Neutrophils [#/volume] in Blood by Automated count

12784

69115

1.58

241.91

9.3

6.4

e9/l

4.1

4.3

8.86

11066

58852

(40768800) Prostate Pathology biopsy report

594

858

4.86

229.34

1.2

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3376

12884

1.93

228.42

4.5

2.7

u/l

246.9

241.7

1.10

3188

11913

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11388

60610

1.56

223.58

6.3

5.3

mmol/l

1.2

0.74

10160

53504

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12304

67039

1.54

213.34

7.1

5.7

mmol/l

1.2

0.21

10280

56146

(1617658) Protocol used for examination of sentinel lymph nodes

158

60.77

205.18

1.1

1.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

15172

87107

1.54

201.04

5.3

4.5

e6/l

1024.8

1615.1

0.85

175

1314

(40768793) Breast Pathology biopsy report

523

781

4.69

194.42

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

7393

36570

1.56

192.21

2.6

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

10410

55511

1.51

191.68

4.2

3.7

—

(3023368) Bacteria identified in Blood by Culture

6989

34662

1.55

176.21

4.5

4.0

—

(3032080) INR in Blood by Coagulation assay

10279

55544

1.48

170.35

11.0

9.9

inr

1.3

1.03

2839

15217

(40758558) Short blood count panel - Blood

6043

29238

1.56

168.57

7.1

4.8

—

(3030467) Casts [#/volume] in Urine by Automated count

7166

36233

1.51

162.34

3.6

3.0

e6/l

0.4

0.91

5487

26988

(3018418) pH of Serum or Plasma

7612

39036

1.50

160.81

4.7

3.3

7.4

0.81

1371

6746

(36304419) Bacteria [Presence] in Urine

6915

34782

1.52

160.06

3.6

2.9

—

(40768795) Lymph node Pathology biopsy report

274

267

7.13

153.93

1.2

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

211

144

10.16

152.89

3.0

1.1

u/ml

45.1

22.1

1.34

205

133

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5749

28053

1.54

151.54

2.5

2.2

—

(3002582) Erythrocytes [#/volume] in Urine

7594

39355

1.48

149.73

3.8

3.1

e6/l

88.6

94.4

0.10

5851

29817

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5026

23958

1.56

146.27

3.2

2.2

mmol/l

2.5

4.97

4342

20350

(3018095) Leukocytes [#/volume] in Urine

8651

46153

1.45

145.93

4.3

3.5

e6/l

99.3

115.4

0.87

6296

32334

(3033658) Prothrombin time (PT) actual/Normal

6159

30746

1.51

144.83

4.2

3.6

85.3

87.6

9.03

6029

29887

(42870588) Differential panel, method unspecified - Blood

8038

42640

1.45

137.49

6.5

5.5

—

(3006315) Basophils [#/volume] in Blood

11194

63250

1.41

133.42

6.4

5.5

e9/l

0.0

5.52

9542

53916

(3013826) Glucose [Moles/volume] in Serum or Plasma

13448

78453

1.41

133.04

4.8

4.4

mmol/l

6.7

6.8

6.82

12721

73100

(3001604) Monocytes [#/volume] in Blood

11128

62867

1.40

132.34

6.4

5.4

e9/l

0.6

0.37

9484

53550

(3000850) Epithelial cells [#/volume] in Urine

5510

27416

1.50

128.97

2.9

2.5

e6/l

4.5

5.2

5.02

4767

23671

(3019198) Lymphocytes [#/volume] in Blood

11345

64502

1.40

128.54

6.5

5.5

e9/l

2.0

1.9

3.81

9833

55995

(3013115) Eosinophils [#/volume] in Blood

11464

65314

1.40

128.15

6.6

5.6

e9/l

0.2

10.42

9910

56503

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

207

180

7.97

127.15

1.2

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

20538

130211

1.58

126.40

17.9

13.5

mg/l

26.1

23.8

15.37

16628

102092

(3037467) Urinalysis macro (dipstick) panel - Urine

15301

91744

1.40

124.96

5.0

4.4

—

(3026782) Osmolality of Urine

5135

25321

1.50

124.90

3.2

2.7

mosm/kgh2o

543.4

542.7

0.08

4323

21110

(3019069) Monocytes/100 leukocytes in Blood

10390

58553

1.39

121.45

7.1

6.0

8.8

8.7

2.58

9590

53989

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

935

2761

2.38

118.58

3.1

2.0

u/ml

3324.5

132.5

0.60

793

2235

(3006504) Eosinophils/100 leukocytes in Blood

10321

58266

1.38

118.24

6.8

5.7

2.8

3.0

13.39

9501

53483

(3022096) Basophils/100 leukocytes in Blood

10065

56620

1.38

117.59

6.8

5.7

0.7

2.66

9256

52017

(3002030) Lymphocytes/100 leukocytes in Blood

10550

59839

1.38

117.01

7.0

5.8

26.9

27.5

4.97

9685

54831

(3026008) Bacteria identified in Urine by Culture

7710

41598

1.40

114.56

3.6

3.2

—

(3018010) Neutrophils/100 leukocytes in Blood

10409

59148

1.37

112.54

6.6

5.6

58.1

57.6

4.23

9591

54485

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8591

47339

1.39

112.03

5.8

3.9

ug/l

3.4

2.3

4.88

7543

42348

(3019550) Sodium [Moles/volume] in Serum or Plasma

21547

139065

1.63

108.88

21.3

16.3

mmol/l

139.7

139.8

6.94

21034

135084

(3027945) Reticulocytes/100 erythrocytes in Blood

3282

15112

1.57

107.22

2.6

2.2

1.8

0.15

2846

13076

(3023103) Potassium [Moles/volume] in Serum or Plasma

21575

139396

1.62

106.72

21.5

16.4

mmol/l

4.0

0.36

21028

135179

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6402

33786

1.41

106.12

2.4

2.3

mg/l

3.1

3.0

2.67

5354

28540

(3049717) Cytology report of Urine Cyto stain

1288

4543

2.00

105.34

2.8

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3952

19045

1.51

104.85

3.2

2.5

mmol/l

0.8

1.71

3621

17330

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

120

13.38

101.58

1.3

1.1

ug/l

1.8

2.8

0.51

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8117

44898

1.37

100.23

3.1

ng/l

1810.4

1513.6

5.69

6997

38501

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4168

20508

1.48

99.33

3.4

2.7

e6/l

2.1

2.9

5.28

2314

11017

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5132

26289

1.44

99.17

3.5

2.8

ug/l

0.8

0.7

6.78

3763

18212

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4532

22718

1.46

98.09

3.1

2.6

e6/l

1.1

1.2

0.88

2653

13126

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2277

9801

1.66

97.22

2.2

2.0

g/l

0.2

0.16

2096

8859

(3020564) Creatinine [Moles/volume] in Serum or Plasma

21576

140075

1.57

93.37

21.3

15.7

umol/l

84.0

79.4

48.54

21563

140013

(3023520) Reticulocytes [#/volume] in Blood

2533

11317

1.60

93.00

2.8

2.2

e9/l

68.1

69.4

0.89

1894

8611

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4260

21343

1.45

91.65

1.9

1.8

—

(3044889) 12 lead EKG panel

15585

95771

1.34

91.14

4.6

4.0

—

(3021589) Normoblasts [#/volume] in Blood

9797

56328

1.33

91.07

11.2

8.7

e9/l

0.0

0.04

8019

46057

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

21548

139997

1.56

90.58

12.2

9.5

u/l

24.4

25.5

11.96

20542

133524

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6909

37752

1.36

89.65

4.9

3.8

22.2

24.2

20.42

3758

18524

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

19504

124372

1.41

88.50

17.3

12.4

ml/min/173m2

72.4

75.9

109.22

16428

100010

(40761511) CBC panel - Blood by Automated count

20891

135034

1.49

86.92

17.0

13.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10429

61044

1.31

82.41

2.2

2.0

pmol/l

95.5

0.02

5241

30623

(3013707) Erythrocyte sedimentation rate by Westergren method

16107

100085

1.32

81.82

4.5

4.2

mm/h

13.7

12.7

13.61

14589

91772

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3597

17863

1.45

79.81

2.9

2.6

21.8

22.4

1.53

3059

14903

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3354

16436

1.47

79.70

6.8

5.3

mmol/l

1.0

0.02

3071

15072

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8964

51609

1.31

78.70

3.0

2.8

ug/l

152.8

132.8

4.33

8064

46986

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3797

19125

1.43

77.91

2.8

2.5

g/l

2.3

7.37

3467

17458

(3000963) Hemoglobin [Mass/volume] in Blood

22032

144600

1.57

76.76

27.0

20.0

g/l

132.8

135.6

143.12

21676

141744

(3024731) MCV [Entitic volume]

22029

144577

1.57

76.74

26.8

19.8

91.8

91.5

23.85

21681

141704

(3007461) Platelets [#/volume] in Blood

22021

144516

1.57

76.67

26.9

19.9

e9/l

239.1

246.6

52.18

21388

139598

(3026361) Erythrocytes [#/volume] in Blood

22029

144585

1.57

76.59

26.9

19.9

e12/l

4.4

4.5

120.88

21322

139045

(3035941) MCH [Entitic mass]

22024

144558

1.56

76.34

26.7

19.8

30.4

1.71

21676

141693

(3010813) Leukocytes [#/volume] in Blood

22028

144597

1.56

76.21

26.9

19.9

e9/l

6.8

6.7

5.81

21322

139078

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

610

1815

2.35

75.88

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

4061

20802

1.41

75.63

2.8

2.5

umol/l

12.2

12.8

5.36

3706

18989

(3007853) Bacteria identified in Skin by Aerobe culture

3067

14944

1.47

74.60

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

3275

16181

1.45

74.11

6.4

6.6

mmol/l

104.5

104.2

2.54

3220

15762

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

123

111

7.66

73.57

6.0

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9501

55468

1.29

73.56

2.3

2.2

nmol/l

82.0

79.2

15.44

8238

48479

(3021960) Folate [Moles/volume] in Serum or Plasma

6193

34298

1.33

69.62

1.6

1.5

nmol/l

21.0

20.6

1.20

5165

28810

(3042936) Bacteria identified in Isolate by Culture

3473

17541

1.42

69.37

2.0

2.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2995

14817

1.45

66.71

1.8

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

536

1609

2.32

65.37

2.8

1.9

u/ml

718.8

703.5

0.01

481

1442

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2722

13271

1.46

65.34

3.7

3.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

12.15

65.33

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1462

6196

1.66

65.24

1.7

1.6

g/l

1.5

1.6

3.38

1242

5249

(3020630) Protein [Mass/volume] in Serum or Plasma

2371

11253

1.50

65.07

2.8

1.6

g/l

65.9

66.8

6.83

2120

10008

(3019309) Folate [Moles/volume] in Red Blood Cells

5313

29049

1.33

64.35

1.8

nmol/l

1177.4

1164.1

0.45

3834

21643

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2965

14820

1.43

62.13

1.9

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3875

20294

1.37

61.82

32.6

28.0

inr

1.5

1.4

0.74

410

2720

(3020779) Urea [Moles/volume] in Serum or Plasma

2366

11347

1.48

61.50

8.2

7.0

mmol/l

11.1

10.8

0.79

2233

10709

(3000991) Gas panel - Venous blood

2218

10512

1.50

61.08

7.2

8.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1951

9017

1.53

60.45

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3876

20378

1.37

60.18

2.0

1.9

30.1

29.9

1.13

3770

19734

(3019420) Tryptase [Mass/volume] in Serum or Plasma

241

494

3.38

59.32

1.2

1.5

ug/l

6.7

9.7

1.84

228

430

(3002385) Erythrocyte distribution width [Ratio]

16600

105290

1.27

58.66

22.2

16.1

13.9

13.7

31.01

16245

102579

(3022145) Colonoscopy Study observation

2746

13770

1.42

56.09

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

18976

122669

1.30

55.69

5.0

4.8

mu/l

2.2

2.1

0.30

16944

110813

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2212

10665

1.47

55.68

4.1

3.7

ng/l

99.5

92.6

2.08

1873

8978

(3010375) cycloSPORINE [Mass/volume] in Blood

223

455

3.39

55.30

32.4

27.8

ug/l

96.8

115.1

5.18

203

376

(3014111) Lactate [Moles/volume] in Serum or Plasma

2292

11168

1.46

54.58

5.9

6.8

mmol/l

1.4

0.48

2210

10737

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

291

705

2.86

54.55

1.7

1.3

ug/l

26.2

23.9

0.15

285

683

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2650

13301

1.42

53.68

3.0

2.2

umol/l

7.7

7.8

0.04

2286

11373

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1004

4074

1.73

52.39

2.5

3.1

u/ml

0.4

0.42

554

2411

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

9281

55535

1.24

52.30

4.2

3.8

ng/l

82.6

76.8

0.05

7085

40045

(3042111) Morphology [Interpretation] in Bone marrow Narrative

496

1587

2.17

52.09

1.5

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

644

2278

1.97

51.91

1.6

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

20208

132097

1.33

51.49

5.3

5.0

mmol/l

6.0

9.74

17955

119320

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2228

10923

1.44

51.20

2.5

2.2

u/l

44.5

42.6

0.07

1910

9197

(3009542) Hematocrit [Volume Fraction] of Blood

17747

114146

1.26

50.68

19.9

15.0

38.8

39.3

7.30

11227

74339

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

537

1800

2.08

50.13

6.1

5.7

iu/ml

1020.6

918.7

0.07

270

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1698

7946

1.51

49.26

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

10854

66329

1.23

49.13

4.3

3.9

estimate

0.0

0.04

2033

11045

(3021601) Nitrite [Presence] in Urine by Test strip

10731

65532

1.23

48.75

5.6

5.1

estimate

0.0

1.60

2065

11345

(3035350) Ketones [Presence] in Urine by Test strip

10719

65506

1.23

48.10

4.2

3.8

estimate

0.0

0.50

2052

11143

(3045142) Bone marrow Pathology biopsy report

328

910

2.50

47.51

1.3

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

237

556

2.95

47.06

1.8

1.4

mg/l

4.2

3.9

0.53

222

528

(3026493) Urate [Moles/volume] in Serum or Plasma

6340

36715

1.26

46.33

3.1

2.4

umol/l

5666.6

5633.4

0.02

5319

31110

(3003434) Protein [Mass/volume] in Pleural fluid

452

1465

2.14

46.02

1.4

1.5

g/l

31.4

29.8

1.72

392

1283

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

993

4184

1.66

45.03

2.6

2.9

—

(3015736) pH of Urine

8538

51208

1.23

44.87

4.0

3.6

6.0

5.4

1.72

(40768806) Pleura Pathology biopsy report

347

1023

2.35

44.18

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

423

1362

2.16

43.80

3.0

2.6

u/ml

356.6

7653.0

0.53

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

269

706

2.64

43.57

3.2

1.6

nmol/l

6.6

4.5

0.69

260

671

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

991

4240

1.63

42.32

3.6

1.5

u/ml

60.9

28.8

3.12

953

4023

(3004588) Protein electrophoresis panel - Serum or Plasma

1978

9834

1.42

41.71

2.6

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

716

2817

1.77

41.55

1.8

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4918

27952

1.26

41.32

4.1

4.0

ng/l

331.9

552.1

5.38

4235

22855

(3013512) EKG study

7144

42331

1.23

41.24

4.5

4.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1445

6792

1.49

40.83

2.0

2.1

nmol/l

12.3

14.6

17.82

1249

5909

(3017181) Myelocytes/100 leukocytes in Blood

2041

10244

1.40

40.73

4.4

3.8

1.0

0.8

2.49

591

2154

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7034

41674

1.23

40.47

2.6

2.3

u/l

59.7

60.0

0.07

6381

37908

(21494815) CD4 cells/100 lymphocytes in Specimen

225

559

2.79

40.44

1.8

2.0

36.6

44.8

1.69

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1653

8024

1.45

39.64

7.6

9.0

0.7

0.88

1648

7971

(3027801) Oxygen [Partial pressure] in Arterial blood

2850

15165

1.33

39.32

6.2

7.0

kpa

12.2

11.6

6.30

2712

14419

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2850

15175

1.33

39.13

6.2

7.0

kpa

5.0

5.1

0.54

2711

14437

(3003396) Base excess in Arterial blood by calculation

2835

15136

1.33

38.13

6.2

7.0

mmol/l

0.9

1.3

6.80

2219

11805

(3012441) Differential panel - Pleural fluid

347

1097

2.19

37.65

1.4

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1492

7181

1.46

37.35

6.0

7.2

mmol/l

24.7

24.9

1.03

1485

7099

(3037756) Immunofixation for Serum or Plasma

679

2721

1.74

37.00

1.6

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

1947

9876

1.39

36.35

4.4

3.8

0.1

1.25

553

2010

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

20519

135611

1.28

36.21

5.6

5.5

mmol/l

2.6

2.7

41.94

18398

124006

(3000494) Fungus identified in Specimen by Culture

2830

15222

1.32

35.97

1.5

1.4

—

(3011412) CD3 cells [#/volume] in Blood

242

666

2.51

35.77

2.1

2.0

e9/l

1.1

1.0

0.64

143

355

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

185

442

2.89

35.72

1.8

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

19377

127268

1.24

35.60

6.5

6.4

mmol/mol

40.0

40.5

10.06

17481

116650

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2342

12299

1.34

35.07

6.8

7.8

g/l

119.8

122.3

6.85

2260

11833

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

15768

101564

1.20

34.76

4.0

pmol/l

15.1

14.9

6.51

13947

91001

(3036782) Glucose [Moles/volume] in Pleural fluid

313

981

2.21

34.71

1.3

mmol/l

6.1

6.7

3.06

288

898

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

311

974

2.21

34.56

1.3

u/l

479.0

411.9

0.20

295

906

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1018

4611

1.54

34.14

2.9

1.5

g/l

1.2

0.5

6.04

858

3882

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1378

6660

1.45

33.69

7.8

9.1

mmol/l

24.2

24.5

2.01

1273

6039

(3028308) Erythrocytes [#/volume] in Pleural fluid

353

1180

2.07

33.33

1.4

1.5

e6/l

71558.2

58736.1

0.29

199

712

(3025159) Blasts/100 leukocytes in Blood

1839

9391

1.38

32.85

4.4

3.8

0.1

0.2

0.38

471

1751

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2048

10640

1.35

32.81

4.4

3.0

mmol/l

1.2

0.41

1750

8947

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

202

531

2.63

32.76

2.3

2.1

e6/l

592.8

927.0

1.04

252

(3002179) Metamyelocytes/100 leukocytes in Blood

1840

9409

1.37

32.58

4.3

3.6

0.6

0.41

436

1596

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

167

397

2.91

32.58

4.8

1.2

u/ml

132.6

309.6

1.15

(3023199) Leukocytes [#/volume] in Pleural fluid

380

1317

2.00

32.56

1.4

1.5

e6/l

2218.4

3482.5

0.76

253

966

(3016502) Oxygen saturation in Arterial blood

2536

13642

1.31

31.96

6.4

7.3

95.6

95.1

3.65

2446

13118

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1255

6021

1.46

31.86

3.8

4.1

mmol/l

24.1

24.2

0.46

1136

5314

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

158

374

2.92

31.08

2.7

2.4

36.0

43.1

1.66

137

(3045788) Cell count panel - Pleural fluid

308

1005

2.12

30.99

1.4

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1495

7444

1.41

30.98

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

972

4454

1.52

30.91

3.7

1.6

mg/l

45.5

37.8

1.04

802

3589

(3004809) Band form neutrophils/100 leukocytes in Blood

424

1558

1.89

30.71

4.2

2.9

1.5

1.3

0.73

344

1169

(3034860) Kappa light chains.free [Mass/volume] in Serum

973

4470

1.52

30.57

3.7

1.6

mg/l

122.1

47.0

0.72

801

3608

(1175426) CD3 cells/100 lymphocytes in Blood

184

483

2.63

29.97

1.7

1.9

70.4

71.8

0.44

171

457

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

943

4324

1.52

29.89

3.6

1.6

ratio

6.1

2.1

1.09

338

(40768797) Stomach Pathology biopsy report

3343

18781

1.26

29.81

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

676

2884

1.63

29.22

3.6

2.7

mg/l

1.8

1.7

1.43

606

2557

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

246

752

2.26

29.03

1.3

u/l

15.8

12.5

1.00

230

678

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1153

5550

1.45

28.75

2.6

1.4

g/l

7.4

7.5

1.31

850

4056

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

937

4328

1.51

28.70

2.5

1.4

g/l

37.4

37.5

0.36

784

3629

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

178

470

2.62

28.69

1.6

1.9

15.6

15.8

0.04

207

(3003694) ABO and Rh group [Type] in Blood

5045

29733

1.21

28.57

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1150

5545

1.45

28.41

2.6

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4789

28107

1.21

28.26

1.7

mg/l

1.5

1.2

3.94

3694

21642

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1087

5193

1.46

28.18

2.6

1.4

g/l

3.1

0.37

837

3994

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7429

45389

1.18

28.16

2.2

2.1

u/l

209.8

218.7

0.27

6891

42175

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1146

5534

1.45

28.09

2.6

1.4

g/l

3.8

0.67

824

3904

(3052851) Hemolysis interference index of Serum or Plasma

849

3862

1.53

27.93

3.4

3.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1084

5192

1.46

27.73

2.6

1.4

g/l

10.1

10.3

0.39

892

4291

(3011397) Hemoglobin [Presence] in Urine by Test strip

5458

32488

1.20

27.70

4.1

3.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

886

4076

1.51

27.66

2.6

1.5

g/l

0.0

0.53

801

3685

(40765096) Chromosome analysis panel by Banding

170

3.77

27.22

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

821

3733

1.53

27.07

2.7

1.5

g/l

0.0

0.00

746

3404

(3026250) Tacrolimus [Mass/volume] in Blood

161

417

2.67

26.96

29.0

34.7

ug/l

7.0

7.2

0.32

134

379

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

464

1831

1.76

26.77

1.7

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

584

2458

1.65

26.65

1.6

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

830

3796

1.52

26.64

2.6

1.5

g/l

0.0

0.50

748

3416

(40760892) CBC W Ordered Manual Differential panel - Blood

4445

26054

1.21

26.32

4.9

4.2

—

(40761536) Microorganisms panel - Urine sediment

1945

10351

1.32

26.25

4.8

4.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

602

2568

1.63

26.07

1.6

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1623

8470

1.34

25.03

3.4

2.3

g/l

10.4

10.8

2.24

1480

7677

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

770

3513

1.52

25.01

1.6

1.7

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

239

771

2.14

24.86

1.5

1.4

u/l

14.4

13.4

1.03

226

739

(21494755) Public health laboratory ask at order entry panel

700

7183

0.66

24.46

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2390

13187

1.27

24.43

2.9

3.0

ng/l

247.7

223.5

1.34

2187

12099

(3010503) CD19 cells [#/volume] in Blood

162

444

2.52

24.33

2.3

2.1

e9/l

0.2

0.19

152

426

(3017143) Hepatitis C virus Ab [Presence] in Serum

1819

9690

1.32

24.32

1.6

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2320

12765

1.28

24.25

4.0

3.7

kpa

5.8

5.9

2.45

2259

12388

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

39.03

24.25

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

718

3253

1.53

24.09

3.7

1.6

—

(3002032) Base excess in Venous blood by calculation

2313

12737

1.28

24.01

4.0

3.7

mmol/l

1.7

2.0

2.76

1931

10438

(40761535) Cells panel - Urine sediment

2216

12141

1.28

23.95

4.0

3.4

—

(3019225) pH of Specimen

2519

14023

1.26

23.89

4.5

3.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

19945

132562

1.20

23.79

5.0

4.9

mmol/l

4.5

4.6

31.47

17873

121712

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1029

5043

1.42

23.27

1.9

ug/l

2.5

2.1

0.44

873

4379

(3029937) Albumin [Presence] in Urine by Test strip

5951

36210

1.17

22.57

4.9

4.3

estimate

0.0

0.09

1969

11010

(3012544) pH of Venous blood

2386

13294

1.26

22.39

4.0

3.8

7.4

0.70

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1902

10321

1.29

22.10

1.6

1.5

—

(40768441) Liver Pathology biopsy report

175

524

2.31

21.80

1.3

—

(4281824)

212

689

2.13

21.71

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

19752

131431

1.19

21.34

4.9

4.8

mmol/l

1.5

3.56

17586

119865

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

617

2782

1.54

21.20

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

617

2783

1.54

21.16

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1295

6709

1.35

20.93

2.3

1.5

g/l

1.5

1.2

2.40

1145

6052

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

782

3715

1.46

20.90

1.3

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

219

734

2.06

20.74

1.7

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

650

2981

1.51

20.66

2.3

2.4

g/l

3.6

0.30

622

2827

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

20.62

1.0

0.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1163

5943

1.36

20.53

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

161

479

2.32

20.38

2.3

2.0

e9/l

0.3

0.2

0.83

136

427

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

166

504

2.27

20.08

2.2

2.0

e6/l

489.5

501.3

0.05

133

433

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1500

7994

1.31

19.92

2.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

19109

126978

1.17

19.83

4.4

4.3

mmol/l

1.2

1.3

23.40

16820

114779

(3037121) Protein [Mass/volume] in Urine

875

4298

1.42

19.56

3.2

2.6

g/l

0.3

0.13

354

1464

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

11.48

19.55

1.1

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

136

382

2.46

19.52

4.2

3.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

196

3.10

19.36

1.6

2.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

1930

10665

1.27

19.31

3.2

3.1

kpa

4.7

4.5

2.20

1871

10316

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.24

19.17

1.2

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

986

4970

1.38

18.96

1.8

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1905

10544

1.26

18.79

2.3

1.8

nmol/l

373.5

367.4

0.57

1727

9516

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

312

1219

1.77

18.78

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1059

5409

1.36

18.76

2.0

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1275

6704

1.33

18.63

8.3

9.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

131

371

2.44

18.51

2.6

2.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

363

1492

1.68

18.28

1.7

1.5

—

(3016228) CD19 cells/100 cells in Blood

102

259

2.72

17.91

1.6

2.0

9.5

8.8

0.18

249

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

203

708

1.98

17.35

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

596

2793

1.48

17.14

2.6

2.5

15.9

16.4

2.50

333

1460

(21494434) Karyotype in Bone marrow

253

957

1.83

16.99

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

295

1170

1.74

16.92

4.7

2.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

298

1187

1.74

16.84

1.7

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

726

3549

1.42

16.72

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

730

3581

1.41

16.49

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3230

19115

1.19

16.42

8.5

7.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

379

1625

1.61

16.26

1.5

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

249

2.66

16.24

1.7

2.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

730

3592

1.41

16.22

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2102

11972

1.23

15.97

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

288

1157

1.72

15.83

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1907

10765

1.24

15.75

2.9

2.4

ml/min/173m2

57.9

62.3

6.17

853

4216

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2391

13820

1.21

15.67

2.4

ug/l

6.2

7.6

3.29

2013

11952

(3047189) Immunofixation for 24 hour Urine

143

458

2.15

15.36

1.7

1.2

—

(3051651) Icteric interference index of Serum or Plasma

178

624

1.97

15.07

3.6

4.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

123

375

2.26

14.88

1.5

1.4

65.8

63.9

0.23

101

300

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1493

8257

1.26

14.78

3.7

3.4

mmol/l

1.7

1.9

1.52

1104

6112

(3035637) Corticotropin [Mass/volume] in Plasma

258

1028

1.73

14.64

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1560

8682

1.25

14.63

3.7

3.5

kpa

5.1

5.2

3.31

1439

7957

(3036489) Thrombin time

819

4195

1.36

14.31

1.8

1.9

21.8

21.7

0.13

739

3669

(3009343) pH of Capillary blood

1537

8562

1.25

14.30

3.7

3.5

7.4

1.31

242

1046

(21494890) Protein electrophoresis panel - 24 hour Urine

308

1299

1.64

14.18

1.9

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

322

1374

1.62

14.16

3.3

3.4

—

(3000060) B lymphocytes [#/volume] in Blood

144

3.06

13.98

1.7

2.0

e6/l

1656.2

133.5

0.75

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

442

2035

1.50

13.94

1.5

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

152

2.99

13.87

1.5

1.4

10.7

9.3

0.18

(3042631) Mycobacterium sp identified in Specimen

378

1686

1.55

13.80

2.8

2.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

553

2668

1.44

13.77

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

240

954

1.74

13.77

1.5

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

240

954

1.74

13.77

1.5

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

240

954

1.74

13.77

1.5

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10387

67187

1.11

13.48

2.4

—

(3006245) CD3-CD19+ cells/100 cells in Blood

226

2.56

13.33

1.7

1.9

10.9

9.0

0.49

208

(3000570) Elastase.pancreatic [Mass/mass] in Stool

753

3852

1.36

13.30

1.4

ug/g

268.3

283.0

1.27

466

2263

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1468

12333

0.81

13.26

1.6

1.7

1.5

0.81

1206

10484

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

7919

50523

1.12

13.14

4.7

4.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

250

1021

1.69

13.05

1.6

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

585

2883

1.41

12.97

2.2

2.4

208.4

192.4

3.97

546

2708

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

391

1787

1.51

12.82

1.6

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6216

39172

1.12

12.71

3.3

2.6

u/l

34.1

34.5

0.13

5788

36711

(1616796) Gas panel - Central venous blood

575

2838

1.40

12.65

3.8

3.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.60

12.60

1.4

1.1

—

(3035880) pH of Pleural fluid

165

607

1.88

12.24

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

261

1099

1.64

12.17

1.6

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

357

1619

1.52

12.16

6.3

6.2

mg/l

12.2

12.0

0.36

327

1469

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

229

2.47

12.11

1.6

1.8

29.1

26.2

0.83

214

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

148

527

1.94

12.10

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

148

527

1.94

12.10

1.5

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1194

6587

1.26

12.10

2.7

2.8

0.6

0.7

0.48

1144

6295

(3017354) Segmented neutrophils/100 leukocytes in Blood

253

1059

1.65

12.08

3.9

2.8

60.5

61.1

0.14

170

686

(3020891) Body temperature

1045

5674

1.28

12.07

4.6

4.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

103

320

2.22

12.02

1.5

1.4

3.7

2.5

0.69

265

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

12228

80053

1.10

11.93

3.1

3.0

u/l

53.0

48.5

4.80

11029

72985

(3028271) Lactate [Moles/volume] in Capillary blood

436

2070

1.46

11.89

1.9

1.8

mmol/l

1.6

1.7

2.43

424

2025

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

616

3129

1.36

11.44

2.0

2.1

89.1

90.5

0.81

580

2887

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

302

1340

1.56

11.38

3.7

—

(3010421) pH of Blood

654

3364

1.35

11.21

4.0

7.4

1.78

562

2812

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

259

1115

1.60

11.11

2.7

2.8

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1206

6728

1.25

11.10

2.7

2.8

1.1

1.2

4.79

1200

6697

(3027456) Digoxin [Moles/volume] in Serum or Plasma

643

3306

1.35

11.06

3.4

3.1

nmol/l

0.8

1.19

498

2572

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

17.70

10.85

1.1

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

378

1783

1.47

10.71

1.5

1.4

u/ml

20.1

15.1

0.40

(3027315) Oxygen [Partial pressure] in Blood

574

2917

1.36

10.66

4.1

kpa

8.5

8.4

0.97

568

2835

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

398

1899

1.45

10.63

1.5

1.4

pmol/l

194.5

82.4

2.25

384

1858

(3012501) Base excess in Blood by calculation

568

2891

1.36

10.45

4.1

mmol/l

2.5

2.6

0.60

388

1979

(3013290) Carbon dioxide [Partial pressure] in Blood

568

2893

1.36

10.41

4.1

kpa

4.9

5.0

3.27

562

2812

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

342

1594

1.48

10.31

1.6

1.4

u/ml

111.1

118.9

0.73

352

(3024316) Viscosity of Plasma

6.26

10.29

1.4

mpas

1.9

1.4

1.19

(3007164) IgA [Mass/volume] in Serum or Plasma

3592

22138

1.14

10.28

1.6

1.3

g/l

2.5

2.6

1.03

1959

12455

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

158

609

1.79

10.20

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

157

605

1.79

10.15

1.6

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

914

5003

1.27

9.94

2.3

ug/l

416.5

623.3

1.84

854

4695

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

478

2387

1.39

9.92

3.8

3.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

+∞

9.86

1.1

0.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

213

902

1.63

9.82

1.6

1.4

—

(3019060) Gas panel - Arterial blood

1602

9326

1.19

9.67

4.1

4.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

400

1946

1.42

9.67

1.3

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

373

1794

1.44

9.60

1.5

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

443

2200

1.39

9.52

1.3

1.2

u/l

51.2

25.2

2.16

376

1889

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

286

1308

1.51

9.49

1.2

u/l

61.0

57.9

0.35

195

841

(44806118)

261

1173

1.54

9.39

1.6

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

5279

33437

1.11

9.36

4.1

3.5

—

(44790049)

261

1174

1.54

9.35

1.6

1.5

—

(44790047)

261

1174

1.54

9.35

1.6

1.5

—

(44790048)

261

1174

1.54

9.35

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

138

525

1.81

9.35

1.6

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

138

525

1.81

9.35

1.6

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

138

525

1.81

9.35

1.6

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

176

721

1.68

9.24

1.6

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

138

527

1.81

9.24

1.6

1.3

—

(3048879) Bone marrow aspiration report

315

2.06

9.20

1.4

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

330

1569

1.45

9.06

1.5

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

227

2.25

9.02

2.1

1.4

u/l

21.6

36.0

0.82

202

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

259

2.16

8.95

1.4

1.3

ug/l

94.6

38.2

0.54

121

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

108

386

1.93

8.87

1.7

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

108

387

1.92

8.81

1.7

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

109

393

1.91

8.74

1.7

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

605

3198

1.31

8.69

2.3

2.1

g/l

126.9

130.4

2.75

435

2315

(3048689) Calprotectin [Mass/mass] in Stool

2343

14183

1.15

8.68

2.3

2.1

ug/g

138.4

139.7

0.06

1809

10923

(3024928) Oxygen saturation in Venous blood

551

2877

1.32

8.64

2.5

3.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

242

1091

1.53

8.63

1.8

1.7

g/24h

0.4

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

553

2900

1.32

8.42

3.0

2.9

kpa

8.0

7.9

0.89

525

2691

(3021901) Oxygen saturation in Capillary blood

489

2521

1.34

8.38

2.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

527

2749

1.33

8.34

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

949

5340

1.23

8.15

4.0

3.8

mmol/l

24.8

24.9

0.63

855

4868

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.57

8.11

1.8

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

298

2.01

8.10

1.4

20.0

22.0

0.25

266

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

181

775

1.61

8.08

1.6

1.5

u/l

9.5

6.0

0.95

343

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

341

1678

1.40

7.83

1.2

—

(3000012) Reticulocyte production index

173

741

1.61

7.74

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

320

1561

1.42

7.72

1.1

g/l

1.5

0.30

287

1391

(3014891) Appearance of Pleural fluid

177

2.30

7.63

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

102

378

1.86

7.60

1.6

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

265

2.03

7.46

2.9

2.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

321

1580

1.40

7.39

1.3

1.2

u/ml

300.5

292.4

0.18

190

1018

(3048929) Epstein Barr virus Ab [Presence] in Serum

434

2247

1.33

7.29

1.3

1.2

—

(3022313) Gas panel - Capillary blood

1079

6232

1.20

7.16

3.9

3.6

—

(40758292) HTLV I+II Ab panel - Serum

3.06

7.16

1.4

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

192

1979

0.66

7.14

1.1

iu/ml

71.2

6473.7

0.56

376

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4976

31795

1.10

7.13

1.7

pmol/l

27614112.8

32847715.9

0.28

3893

25786

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

369

1871

1.36

7.12

2.0

2.1

mg/l

28.9

26.6

0.26

104

488

(3015235) Bicarbonate [Moles/volume] in Capillary blood

645

3532

1.26

7.11

3.1

mmol/l

24.6

24.9

1.59

582

3112

(3004119) Hemoglobin [Mass/volume] in Venous blood

1479

8782

1.17

7.11

3.4

3.3

g/l

126.3

130.0

8.60

1439

8568

(3043409) Potassium [Moles/volume] in Arterial blood

774

4331

1.24

7.06

4.0

4.4

mmol/l

3.9

0.26

743

4077

(3018405) Lactate [Moles/volume] in Arterial blood

877

4973

1.22

7.05

3.8

4.1

mmol/l

1.4

0.30

867

4876

(3009508) Creatinine [Moles/volume] in Urine

7244

47126

1.08

6.77

3.3

3.2

mmol/l

6.9

7.3

9.89

5870

39275

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

185

834

1.53

6.71

1.3

—

(3003181) Sodium [Moles/volume] in Urine

477

2535

1.30

6.70

1.3

mmol/l

59.4

63.5

1.51

392

2018

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

144

2.34

6.68

1.1

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1477

8813

1.16

6.68

6.3

6.9

mmol/l

24.5

24.6

1.23

1379

8202

(3023383) Lactate [Moles/volume] in Pleural fluid

326

1.86

6.62

1.3

1.4

mmol/l

3.8

3.3

0.73

293

(3025468) Yersinia sp identified in Specimen by Organism specific culture

319

1600

1.38

6.62

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

888

5075

1.21

6.62

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

319

1601

1.38

6.60

1.4

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

322

1620

1.37

6.56

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

319

1606

1.37

6.48

1.4

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5885

38028

1.09

6.44

1.6

1.7

mmol/l

1.3

5.13

4802

31321

(3024522) Salmonella sp identified in Specimen by Organism specific culture

321

1620

1.37

6.43

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

330

1674

1.36

6.40

1.4

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

181

822

1.52

6.38

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

234

2.00

6.35

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

165

736

1.55

6.31

1.2

u/l

27.1

22.7

0.58

140

617

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

106

2.53

6.28

1.7

1.2

—

(3025941) Bacteria identified in Stool by Culture

1124

6612

1.18

6.11

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2962

18586

1.11

6.07

4.9

5.0

33.7

32.8

3.60

1872

12392

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

310

2854

0.74

6.03

1.5

—

(3012516) Albumin [Mass/volume] in Urine

7106

46376

1.08

5.95

3.4

3.2

mg/l

384.4

325.1

0.51

4368

28853

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

167

760

1.52

5.87

1.2

u/l

99.6

86.6

0.74

144

654

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

168

766

1.51

5.85

2.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

128

2.31

5.76

1.5

1.3

14.2

26.3

1.97

(3000764) Benzodiazepines [Presence] in Urine

146

1510

0.66

5.63

1.4

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

193

2.03

5.60

12.1

11.5

mmol/l

5.7

5.1

0.53

193

(3023419) Bacteria identified in Sputum by Culture

339

1766

1.33

5.58

2.7

2.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

320

1.79

5.58

1.3

2.0

u/ml

4513.5

38283.5

0.70

(3001019) Free T4 and TSH panel - Serum or Plasma

485

4168

0.80

5.55

1.6

1.7

—

(3036603) Volume of Urine

172

798

1.49

5.54

1.6

1.4

1747.2

1955.1

0.81

197

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1187

7071

1.16

5.54

3.4

2.6

e6/l

0.3

0.49

1163

6882

(3028300) Cannabinoids [Presence] in Urine

148

1519

0.67

5.50

1.4

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

162

744

1.50

5.48

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

142

634

1.54

5.47

1.9

1.6

—

(3027008) Opiates [Presence] in Urine

148

1516

0.67

5.45

1.4

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

201

967

1.43

5.39

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

989

0.60

5.35

1.1

1.4

promille

0.9

1.3

2.72

748

(1001926) Buprenorphine [Presence] in Urine by Screen method

108

1175

0.63

5.32

1.5

1.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.82

5.31

1.1

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

114

487

1.61

5.31

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

151

2.14

5.30

1.6

1.5

—

(3016879) Cocaine [Presence] in Urine

136

1407

0.66

5.28

1.4

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

159

735

1.49

5.24

2.0

1.8

—

(3046861) Legionella sp Ag [Presence] in Urine

2.84

5.22

1.0

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

148

2.14

5.18

6.5

4.7

—

(3028707) Methadone [Presence] in Urine by Screen method

750

0.55

5.12

1.7

1.9

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

168

2.05

5.05

3.5

2.5

mg/l

21.8

50.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

506

2812

1.24

5.04

1.4

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

114

2.29

5.04

2.2

1.2

ng/l

145.8

100.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

677

3877

1.21

5.04

1.6

g/l

1.2

0.07

646

3666

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.66

4.99

1.8

1.3

nmol/l

316.7

574.1

1.31

(3027944) Amphetamines [Presence] in Urine

147

1479

0.68

4.98

1.4

1.7

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.59

4.95

2.2

4.4

mg/l

1.1

1.5

1.18

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

608

5031

0.83

4.87

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

117

518

1.56

4.74

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

100

2.34

4.73

1.1

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

7442

48954

1.07

4.73

4.1

4.0

mg/mmol

9.6

8.4

1.23

4467

30528

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

322

2843

0.78

4.70

1.9

1.5

nmol/l

0.8

0.12

268

2330

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

136

2.13

4.69

2.2

2.5

—

(3017732) Neutrophils [#/volume] in Blood

1436

8777

1.13

4.68

3.0

2.9

e9/l

4.2

4.0

1.02

1013

6349

(3017704) Immunofixation for Urine

158

748

1.46

4.68

1.4

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

299

1.73

4.58

1.7

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1029

6162

1.16

4.54

1.6

1.5

u/ml

14.1

16.8

0.26

146

(40761539) Cells [Type] in Urine sediment by Light microscopy

285

1.74

4.51

1.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

+∞

4.48

1.0

0.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

132

609

1.49

4.46

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

132

609

1.49

4.46

1.3

—

(3008295) Osmolality of Serum or Plasma

237

1221

1.34

4.32

1.3

1.4

mosm/kgh2o

277.1

276.2

0.20

173

922

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1421

8728

1.13

4.30

2.5

2.4

au/ml

33.5

30.5

0.23

355

(3035947) Staphylolysin Ab [Units/volume] in Serum

138

649

1.47

4.26

1.2

1.1

iu/ml

3.2

4.2

—

(3003338) MCHC [Mass/volume]

15948

107510

1.06

4.24

24.4

17.9

g/l

331.1

332.0

26.86

15820

106597

(3004451) EKG impression Narrative

145

691

1.45

4.19

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

251

1.76

4.17

1.4

21.2

25.8

0.74

206

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

636

5159

0.84

4.14

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1175

7152

1.14

4.13

3.0

pmol/l

4.4

0.43

1001

6245

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

480

0.50

4.12

10.3

11.6

nmol/l

808.1

817.3

0.03

452

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.53

4.12

2.6

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

268

1.72

4.09

1.3

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

551

4519

0.83

4.08

1.6

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

385

3267

0.81

4.05

1.5

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

144

692

1.43

4.01

3.7

4.0

—

(3014271) Vancomycin [Susceptibility]

169

837

1.39

3.97

3.2

3.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

132

2.03

3.95

2.8

1.6

—

(40768446) Kidney Pathology biopsy report

443

1.54

3.91

1.6

—

(3011288) Drugs identified in Urine by Screen method

987

0.66

3.89

1.9

2.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.68

3.86

4.7

4.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1091

6641

1.14

3.85

4.4

3.9

48.9

47.4

1.18

1081

6564

(3033799) Differential panel - Peritoneal fluid

306

1.64

3.78

1.8

2.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.82

3.62

1.1

1.0

—

(1761868) Lipid panel - Serum or Plasma

5799

41712

0.94

3.62

3.3

3.2

—

(3028433) Virus identified in Specimen by Culture

382

1.55

3.55

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

293

1601

1.26

3.52

5.0

12.7

mmol/l

7.0

7.6

1.87

236

1306

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1278

7905

1.12

3.49

1.3

au/ml

57.4

52.2

0.28

326

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

898

5435

1.14

3.49

1.9

u/l

38.8

39.0

0.10

764

4705

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

665

3943

1.16

3.44

1.5

iu/ml

10.3

16.4

1.11

101

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1035

7986

0.89

3.41

1.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

322

1.58

3.35

1.6

umol/l

2.2

2.0

0.78

298

(4198724)

249

0.39

3.33

1.1

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

108

2.04

3.31

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

645

1.40

3.27

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

109

2.02

3.24

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

109

2.02

3.24

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

151

766

1.36

3.16

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

107

512

1.44

3.14

2.8

2.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.30

3.11

8.4

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

453

0.56

3.10

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

248

1.64

3.10

1.1

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

116

1.96

3.09

1.2

—

(3008898) HLA-B27 [Presence]

403

3304

0.84

3.07

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

254

1.63

3.07

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.26

3.07

6.0

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

822

6385

0.88

3.06

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

187

1.73

3.02

2.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

103

2.00

3.00

1.2

1.1

mg/l

6.9

9.2

0.81

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.23

2.98

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

214

1.67

2.97

1.0

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

338

1.53

2.96

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

118

1.93

2.95

1.2

1.1

u/l

20.7

18.1

0.22

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

576

3424

1.16

2.95

2.0

1.9

mg/l

11.7

11.3

0.49

530

3152

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

138

700

1.36

2.92

1.3

nmol/l

0.3

0.2

0.32

105

513

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

787

4786

1.14

2.91

1.6

titre

189.7

265.1

0.40

242

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

132

1220

0.74

2.87

1.1

1.0

ng/l

37.5

45.5

1.45

817

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

126

633

1.37

2.84

1.2

1.1

u/l

83.9

83.6

0.01

102

485

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

126

634

1.37

2.82

1.2

1.1

u/l

28.6

21.7

0.71

466

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

132

1216

0.75

2.82

1.1

1.0

ng/l

706.0

716.5

0.09

798

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

111

1.92

2.78

1.2

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1147

7157

1.11

2.74

3.9

3.3

mmol/l

25.1

25.4

2.17

1116

6942

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

328

1.51

2.74

1.9

2.2

e6/l

12631.6

14868.8

0.11

167

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

132

1209

0.75

2.72

1.1

1.0

ng/l

297.3

336.3

1.05

825

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

184

1.68

2.66

1.1

1.3

ng/l

130.7

124.8

0.03

131

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

630

1.36

2.64

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

128

654

1.35

2.63

2.4

2.3

—

(3021788) Differential panel - Synovial fluid

491

2913

1.16

2.62

1.5

—

(3045424) Erythrocytes [Presence] in Urine

398

2322

1.18

2.62

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

468

2768

1.17

2.60

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

244

1.58

2.60

1.5

1.6

g/l

29.5

49.1

0.37

183

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.13

2.60

2.0

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

155

1.73

2.56

2.2

2.1

—

(3012565) Volume of 24 hour Urine

121

616

1.35

2.55

2.0

1.9

1698.2

1929.4

1.62

107

531

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

4.23

2.53

6.6

3.6

mg/l

3.8

4.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

359

2084

1.19

2.52

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

205

1750

0.80

2.44

1.8

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

155

824

1.30

2.44

2.3

2.0

umol/l

15.7

16.1

0.05

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

394

3165

0.85

2.44

1.1

u/ml

9.0

9.9

0.07

275

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

159

1.69

2.37

2.2

2.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

165

1.67

2.33

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

257

1.53

2.32

1.9

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4019

26460

1.05

2.32

1.3

1.2

u/ml

1.6

1.7

0.15

941

6877

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.88

2.31

1.4

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3019

21854

0.94

2.30

1.3

u/ml

15.5

14.8

0.16

982

7979

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

233

1313

1.22

2.27

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

151

1.69

2.25

5.0

1.4

u/l

40.9

63.0

0.65

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

104

529

1.35

2.25

3.7

2.1

u/l

214.5

205.5

0.69

104

523

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

136

721

1.30

2.22

2.0

2.2

ug/min

94.2

129.5

0.34

171

(3016038) Potassium [Moles/volume] in Urine

177

971

1.26

2.21

1.1

mmol/l

35.6

33.8

0.46

148

801

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

148

1.67

2.15

1.2

1.1

—

(4212803)

112

1.78

2.14

1.1

—

(3013862) HLA-DP [Type]

3.44

2.13

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

174

1483

0.81

2.10

1.1

1.2

mmol/l

7.9

7.6

0.37

125

1042

(3016650) Hepatitis A virus Ab [Presence] in Serum

282

1633

1.19

2.10

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

139

1.68

2.08

1.2

1.3

u/l

145.2

272.9

0.20

(3025577) Chromium [Mass/volume] in Blood

201

1129

1.23

2.06

2.0

2.1

ug/l

2.4

0.04

168

938

(4010399)

1655

10644

1.07

2.05

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

271

1568

1.19

2.04

1.1

au/ml

13.7

14.3

0.04

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.13

2.04

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

374

1.40

2.04

1.9

2.4

e6/l

2163.9

2301.3

0.02

263

(3036525) Urea [Moles/time] in 24 hour Urine

1.92

2.02

3.3

2.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.50

2.02

1.4

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

278

0.57

1.97

6.4

7.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

290

1695

1.18

1.96

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

291

1.44

1.95

1.2

1.1

86.1

90.2

0.32

150

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.20

1.94

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

205

1163

1.21

1.93

1.9

2.0

ug/l

3.5

3.9

0.45

185

1030

(40763590) HLA-DQ beta [Type]

3.44

1.92

1.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

3.44

1.92

1.0

1.1

—

(40760410) HLA-B [Type] by High resolution

3.44

1.92

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.44

1.92

1.0

1.4

—

(40760409) HLA-A [Type] by High resolution

3.44

1.92

1.0

1.1

—

(3024471) HLA-A [Type]

321

1.42

1.91

1.0

—

(3042733) HLA Ab [Presence] in Serum

356

1.39

1.90

5.6

5.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

316

1.42

1.89

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

107

565

1.30

1.86

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

452

1.34

1.85

2.2

1.7

165.7

156.7

0.42

420

(3019150) Specific gravity of Urine by Refractometry

4548

30209

1.04

1.82

5.0

4.3

kg/l

1.0

0.58

631

4630

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

272

2188

0.85

1.81

1.8

1.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.69

1.81

1.0

1.2

2.9

2.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.21

1.80

1.0

1.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

140

1.62

1.80

1.2

ug/l

62.5

122.1

3.08

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.11

1.78

1.0

1.1

21.2

22.0

0.28

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.11

1.78

1.0

1.1

37.2

36.1

0.39

(3044290) Cell count panel - Cerebral spinal fluid

404

2443

1.14

1.77

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

444

1.33

1.76

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

285

1683

1.17

1.74

1.3

1.2

—

(3025315) Body weight

120

1.66

1.74

4.8

5.0

—

(3024932) HLA-DR beta [Type]

316

1.39

1.73

1.1

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

208

1.49

1.72

1.2

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

405

1.34

1.71

7.6

5.8

74.0

70.8

0.63

338

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.75

1.70

2.3

2.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

100

1.72

1.69

1.1

iu/ml

11.3

14.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.78

1.67

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

276

1633

1.16

1.66

1.2

—

(3045414) Leukocytes [Presence] in Urine

983

6260

1.08

1.64

1.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

100

534

1.29

1.64

2.2

4.9

mg/l

2256.6

532.7

0.37

365

(3014133) Dog dander IgE Ab [Units/volume] in Serum

114

985

0.80

1.64

1.1

1.0

u/ml

0.8

2.9

4.34

380

(3042010) Triglyceride [Moles/volume] in Pleural fluid

166

1.53

1.63

1.2

1.3

mmol/l

0.8

1.5

0.63

(43055442) Apixaban [Mass/volume] in Serum or Plasma

223

1.45

1.60

1.5

1.6

ug/l

115.4

120.4

0.10

187

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

146

0.47

1.60

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

236

1896

0.85

1.59

4.1

4.7

umol/l

327.9

358.7

2.49

197

1598

(3029634) Reagin Ab [Titer] in Serum by VDRL

229

1341

1.18

1.58

2.5

2.0

titre

3.6

3.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

344

0.66

1.58

7.2

7.6

—

(3030313) Adrenal Ab [Titer] in Serum

1.93

1.55

1.0

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

295

1766

1.15

1.54

1.3

u/l

13.1

10.7

1.75

235

1401

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.37

1.54

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

224

0.58

1.54

1.3

1.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

163

1.52

1.54

1.1

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

307

1844

1.15

1.54

1.3

1.2

nmol/l

0.2

0.3

0.52

138

(3008401) Mugwort IgE Ab [Units/volume] in Serum

157

1301

0.83

1.53

1.1

u/ml

0.7

0.9

0.26

489

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

206

1200

1.18

1.53

1.5

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

431

2647

1.12

1.53

2.8

2.5

umol/l

33.0

33.2

0.06

351

2243

(3008536) Aspergillus sp Ab [Presence] in Serum

197

1.47

1.52

1.5

—

(3044941) Cell count panel - Synovial fluid

405

2479

1.13

1.52

1.5

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

101

547

1.27

1.51

1.9

101.4

95.6

0.88

509

(3013139) Helicobacter pylori Ag [Presence] in Stool

1428

9253

1.07

1.50

1.2

1.3

—

(3027874) Urate [Moles/volume] in Urine

2.01

1.50

1.0

1.1

mmol/l

1.9

1.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

305

1836

1.14

1.49

1.3

1.2

nmol/l

3.5

2.1

0.20

287

1760

(3023410) Appearance of Cerebral spinal fluid

196

1140

1.18

1.49

1.4

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.90

1.48

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.95

1.48

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

297

1.37

1.47

1.2

1.1

85.0

89.2

0.46

148

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

309

1.36

1.46

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

314

1901

1.14

1.42

2.7

2.4

—

(3051593) INR in Capillary blood by Coagulation assay

140

795

1.21

1.40

11.0

10.7

—

(3024869) Neuronal Ab [Presence] in Serum

231

1.40

1.36

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.93

1.36

1.4

1.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.22

1.36

1.5

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

156

898

1.20

1.36

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3249

23147

0.96

1.35

1.3

iu/ml

34.2

40.5

1.51

1005

7247

(3021387) Prolactin [Units/volume] in Serum or Plasma

255

2006

0.87

1.34

1.9

1.8

mu/l

423.1

311.0

0.34

232

1831

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

136

774

1.21

1.34

1.7

1.4

u/l

5.6

5.8

0.16

113

650

(3016018) Differential panel - Cerebral spinal fluid

213

1261

1.16

1.34

1.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

291

1.35

1.33

1.4

1.6

g/l

15.3

12.6

1.85

210

(3026389) Candida sp identified in Specimen by Organism specific culture

311

1893

1.13

1.32

1.3

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

188

0.59

1.32

1.1

1.4

mmol/l

9.0

9.4

—

104

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

442

1.28

1.31

1.5

1.4

pmol/l

15.6

16.1

0.36

376

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.01

1.31

1.8

1.4

2.5

2.1

0.14

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

156

902

1.19

1.31

1.2

1.3

mmol/l

2.1

2.2

0.38

139

837

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.94

1.30

1.8

1.4

mg/l

1.7

2.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.84

1.30

1.6

1.7

u/l

0.7

0.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.62

1.29

1.0

1.1

u/l

9.0

11.4

0.27

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

459

2862

1.11

1.29

1.2

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

511

1.25

1.28

1.3

umol/l

23.2

22.0

0.14

475

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2483

16414

1.05

1.28

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.15

1.27

1.0

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

154

1.47

1.27

1.9

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.64

1.26

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

366

2258

1.12

1.26

1.4

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

109

612

1.23

1.25

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

110

920

0.82

1.24

1.1

1.0

u/ml

2.6

2.8

0.08

346

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

190

1125

1.16

1.22

2.0

1.7

titre

1146.7

2683.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

158

923

1.18

1.20

2.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.08

1.19

1.0

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

335

2566

0.90

1.18

1.3

iu/l

35.3

36.7

0.31

292

2216

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

481

3023

1.10

1.17

1.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

206

0.63

1.16

1.6

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

540

0.78

1.16

9.2

6.5

mmol/l

24.9

25.3

0.39

487

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

251

1.34

1.15

1.1

—

(3002619) Bacteria identified in Specimen by Culture

263

1.33

1.15

1.3

—

(4034850)

670

4963

0.93

1.15

12.7

10.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

158

928

1.17

1.14

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

287

0.69

1.14

1.5

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

351

0.72

1.14

6.3

6.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

192

1518

0.87

1.13

1.1

u/ml

0.8

1.1

0.53

582

(3007916) DNA double strand Ab [Titer] in Serum

188

0.62

1.13

1.2

1.3

—

184.8

—

(3032057) Clostridioides difficile [Presence] in Stool

324

1.30

1.13

1.7

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

176

1.41

1.12

1.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

436

0.76

1.11

1.7

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

436

0.76

1.11

1.8

2.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

396

0.75

1.10

9.0

7.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

161

0.60

1.10

1.1

1.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

458

2885

1.09

1.2

1.3

titre

109.1

132.3

0.19

(3045716) Anion gap in Serum or Plasma

702

0.81

1.08

3.5

2.3

mmol/l

9.0

8.9

0.07

513

(4062490)

207

1248

1.14

1.07

1.7

1.4

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.19

1.07

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

303

1.29

1.06

2.1

2.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

132

1.46

1.06

1.2

1.4

73.3

66.5

0.62

108

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

184

1.38

1.06

1.2

1.3

nmol/l

242318.1

318674.1

0.10

150

(3000492) Spirometry study

1721

11341

1.05

1.06

1.7

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

104

1.52

1.05

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

797

0.83

1.05

1.2

1.4

nmol/l

1.0

1.2

2.22

608

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

774

4989

1.07

1.04

1.1

u/ml

4.1

5.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

117

677

1.19

1.03

1.5

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

140

1123

0.86

1.03

1.1

u/ml

0.3

1.5

3.22

247

(3049242) von Willebrand panel - Platelet poor plasma

1.94

1.02

1.3

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

429

1.24

1.00

1.1

1.2

g/l

0.6

0.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

170

1338

0.87

0.98

1.1

u/ml

2.6

2.5

0.02

590

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.66

0.98

2.0

1.1

pmol/l

41.6

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

372

0.76

0.97

1.8

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

418

0.77

0.97

1.6

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

615

3947

1.07

0.96

1.7

1.6

e6/l

13935.4

13867.7

0.01

421

2867

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

200

1.34

0.95

1.3

1.2

101.0

83.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

248

1.30

0.95

1.4

titre

334.9

200.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

171

1.37

0.93

1.0

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

205

1250

1.13

0.93

1.7

1.4

g/l

2.6

3.0

3.18

148

872

(3024139) IgG subclass 3 [Mass/volume] in Serum

205

1250

1.13

0.93

1.7

1.4

g/l

0.4

1.32

147

876

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

515

0.80

0.93

1.1

u/ml

2.8

8.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

201

1.34

0.93

1.3

1.2

84.7

74.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.58

0.92

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

205

1251

1.13

0.92

1.7

1.4

g/l

6.1

6.8

2.74

148

871

(36660697) Celiac disease serology panel - Serum

1466

9664

1.05

0.92

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

635

0.82

0.92

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

195

1187

1.13

0.92

2.0

2.1

u/field

2.4

2.3

0.05

431

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

335

1.25

0.91

1.1

1.2

pmol/l

304.7

292.7

0.07

230

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

169

0.65

0.91

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

424

3156

0.92

0.89

3.9

3.5

mg/l

31.8

25.9

2.06

244

2043

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

795

0.85

0.87

1.1

1.0

u/ml

0.1

0.3

0.61

188

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

118

943

0.86

0.87

1.2

mmol/l

11.4

12.0

0.34

277

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

135

805

1.15

0.87

1.3

1.4

umol/l

14.2

13.4

0.47

129

756

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

310

0.75

0.86

1.4

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

204

1.32

0.85

1.1

—

(3039000) Anion gap in Blood

460

2937

1.08

0.85

5.7

6.4

mmol/l

11.2

11.3

0.36

409

2648

(3018572) Chloride [Moles/volume] in Blood

460

2937

1.08

0.85

5.7

6.5

mmol/l

105.0

104.8

0.45

409

2648

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

139

1.39

0.85

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.68

0.83

1.5

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

574

0.83

0.82

1.1

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

257

1947

0.91

0.82

1.2

1.3

miu/ml

181.3

204.6

0.45

799

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

123

0.62

0.82

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.81

0.0

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

482

3091

1.07

0.81

1.3

mg/l

588.2

540.6

0.85

451

2920

(3034274) Bile acid [Moles/volume] in Serum --fasting

103

606

1.17

0.80

1.2

1.5

umol/l

15.7

10.0

0.47

432

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

173

1337

0.89

0.80

1.1

u/ml

3.0

4.1

0.49

499

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

247

1872

0.91

0.80

1.4

1.6

—

(4024509)

240

1494

1.11

0.80

1.6

—

(3016750) Collection duration of Urine

145

876

1.14

0.80

2.6

2.1

min

497.0

500.9

0.20

108

657

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

590

3813

1.07

0.80

1.7

1.6

g/l

0.2

0.31

557

3606

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

225

1.28

0.79

1.4

1.1

ug/l

3.6

2.4

0.53

145

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

469

3457

0.93

0.79

1.3

u/ml

7.3

6.6

0.07

590

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

189

1.31

0.78

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

606

3923

1.06

0.78

1.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.65

0.78

1.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

785

0.86

0.77

1.2

1.4

pmol/l

84.7

111.0

0.27

234

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

897

5875

1.05

0.77

4.5

4.6

1.5

1.6

2.53

840

5531

(3006922) Hepatitis E virus Ab [Presence] in Serum

124

744

1.15

0.76

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

464

3416

0.93

0.76

1.2

1.3

u/ml

6.4

6.1

0.04

381

(3022475) Manganese [Moles/volume] in Blood

1.68

0.76

1.4

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

518

3340

1.07

0.76

1.2

titre

788.3

1110.5

0.73

122

(44816559) Phosphatidylethanol [Mass/volume] in Blood

259

1952

0.91

0.76

1.2

1.3

—

(3024263) Appearance of Synovial fluid

135

816

1.14

0.75

1.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

234

1.26

0.73

1.2

mmol/l

1.3

1.5

0.65

119

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

891

5847

1.05

0.73

1.0

1.1

—

(44806420)

513

0.83

0.72

2.3

—

(3025130) Human papilloma virus identified in Specimen

185

1144

1.11

0.72

1.7

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

724

4727

1.06

0.72

1.7

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

354

0.80

0.72

1.7

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

168

1.31

0.71

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

316

1.22

0.71

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

353

0.80

0.70

1.7

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

145

1121

0.89

0.70

1.2

u/ml

24.5

6.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2327

15574

1.03

0.70

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

614

3994

1.06

0.70

5.1

4.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.91

0.69

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

158

0.70

0.69

1.7

1.9

umol/l

18.2

0.01

158

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

352

0.80

0.69

1.7

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

352

0.80

0.69

1.7

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

121

732

1.14

0.68

1.9

u/field

1.6

2.3

0.94

490

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

117

0.65

0.68

1.5

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.50

0.68

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

236

0.76

0.68

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

546

0.84

0.68

2.1

1.9

ug/l

19.8

444.8

1.43

514

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.66

0.67

1.6

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.54

0.67

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

452

1.17

0.66

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

1105

7310

1.04

0.65

1.3

u/ml

181.0

224.4

0.64

1010

6749

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

512

3731

0.94

0.65

1.2

1.3

u/ml

45.6

41.1

0.10

226

(3041806) Other cells [#/volume] in Blood by Manual count

1.64

0.64

1.6

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

504

1.16

0.64

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

222

1668

0.91

0.64

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

384

2823

0.93

0.64

1.6

1.7

nmol/l

47.6

45.2

1.19

366

2707

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

141

1.32

0.64

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

171

0.72

0.64

1.7

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

289

1.21

0.64

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

877

5778

1.05

0.63

4.6

4.7

0.9

1.05

821

5432

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

155

1184

0.90

0.63

1.2

u/ml

64.8

84.9

—

(3013762) Body weight Measured

1.67

0.63

1.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1939

13715

0.97

0.63

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

105

634

1.14

0.63

1.1

1.2

nmol/l

135.2

137.4

0.16

105

634

(3020961) Endomysium IgA Ab [Titer] in Serum

805

5295

1.05

0.63

1.1

titre

122.7

213.1

0.99

123

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.62

0.0

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

497

3229

1.06

0.62

2.2

2.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

211

1328

1.09

0.61

1.5

iu/ml

29.1

27.2

0.10

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

525

3814

0.95

0.61

1.6

1.7

mg/l

2.9

3.6

1.09

375

2710

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

156

1188

0.90

0.61

1.2

u/ml

34.0

45.9

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

170

1060

1.10

0.60

1.1

1.2

titre

380.0

118.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

307

0.81

0.60

1.8

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.79

0.59

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.38

0.59

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

560

0.86

0.59

1.7

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

470

1.16

0.59

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

515

1.15

0.59

1.2

1.3

g/l

39.9

39.8

0.01

273

(3009871) Measles virus Ab [Titer] in Serum

344

0.82

0.59

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

170

1062

1.10

0.59

1.1

1.2

titre

77.3

178.1

3.92

196

(3006442) Creatine [Moles/volume] in Serum or Plasma

113

873

0.89

0.58

1.5

1.7

umol/l

71.1

70.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

298

0.81

0.58

1.7

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

318

1.19

0.58

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.57

1.0

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

418

2711

1.06

0.57

1.2

mmol/l

3.7

3.9

1.67

379

2549

(3020650) Glucose [Presence] in Urine

287

1.20

0.57

1.3

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

454

0.85

0.56

1.0

u/ml

0.5

0.7

0.53

137

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

297

0.81

0.56

1.1

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

319

1.19

0.56

1.6

1.9

—

(3005033) Fetal Nuchal fold Thickness US

296

0.81

0.55

1.7

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

145

1.28

0.55

1.6

1.7

umol/l

56.3

46.9

0.66

145

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

130

805

1.11

0.54

1.3

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

508

3320

1.05

0.54

1.2

titre

185.7

141.8

0.24

276

(3019832) Treponema pallidum Ab [Presence] in Serum

570

4113

0.95

0.54

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.51

0.54

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

129

799

1.11

0.54

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

134

0.72

0.54

1.4

1.5

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.47

0.54

6.2

5.7

umol/l

443.2

406.6

—

(3011985) Renin [Units/volume] in Plasma

281

1804

1.07

0.53

1.3

mu/l

30.0

57.2

6.70

239

1608

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

112

689

1.12

0.53

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

296

1.19

0.53

2.6

1.6

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.44

0.53

1.4

1.0

nmol/l

202.0

309.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

577

3788

1.05

0.52

1.6

iu/ml

14.6

7.0

0.31

145

838

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.53

0.52

6.2

7.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.53

0.51

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.53

0.51

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

297

1.18

0.51

1.1

—

(3001729) Color of Synovial fluid

132

0.73

0.50

1.2

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

279

1.18

0.50

1.1

1.2

mu/l

83.1

62.9

0.27

193

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

360

2622

0.94

0.50

1.2

u/ml

35.4

49.9

0.85

279

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

111

686

1.11

0.50

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

499

0.87

0.49

1.3

1.7

nmol/l

2.6

4.3

0.79

410

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

269

0.82

0.49

3.4

2.8

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

630

0.88

0.49

1.0

1.1

u/ml

1.7

5.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

318

1.17

0.49

1.1

—

(3006270) Folate [Moles/volume] in Blood

197

1254

1.08

0.48

1.2

nmol/l

312.0

340.0

1.14

163

1017

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.33

0.48

1.1

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

532

1.13

0.47

1.1

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

126

787

1.10

0.47

1.0

1.1

nmol/l

0.9

5.6

4.10

162

(3016244) Insulin [Units/volume] in Serum or Plasma

481

1.13

0.46

2.6

3.1

mu/l

32.1

23.9

0.63

451

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

414

2707

1.05

0.46

1.4

e6/l

83.4

26.7

0.73

309

2127

(3038026) Centromere Ab [Units/volume] in Serum

163

1216

0.92

0.46

1.2

u/ml

80.5

60.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

137

1.26

0.45

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

262

1692

1.07

0.45

1.3

pmol/l

247.2

270.0

1.07

222

1285

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

414

2710

1.05

0.45

1.4

e6/l

6115.5

1524.5

0.41

328

2245

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

106

659

1.11

0.44

1.3

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

175

1.22

0.44

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

183

1168

1.08

0.44

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

339

0.85

0.44

1.7

1.9

mg/l

10.0

9.2

0.37

274

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.64

0.43

1.0

1.1

u/field

0.4

0.6

—

(3004616) Nuclear Ab [Presence] in Serum

244

1788

0.94

0.43

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.63

0.43

2.0

1.4

—

(4015189)

458

1.13

0.43

1.6

2.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.40

0.43

3.3

3.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.41

0.42

1.1

1.4

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

400

2886

0.95

0.42

1.2

u/ml

1.9

7.0

2.41

233

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

189

1.20

0.42

1.2

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.42

0.0

7.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

102

1.28

0.41

1.1

1.3

—

(3001186) Copper [Moles/volume] in Serum or Plasma

266

1.16

0.41

1.1

1.2

umol/l

17.7

16.6

0.80

245

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.29

0.40

1.5

1.6

umol/l

0.8

0.12

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.0

—

141.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

305

1.15

0.40

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

171

1264

0.93

0.40

1.3

nmol/l

1.4

0.19

153

1146

(3009015) Lactate [Moles/volume] in Synovial fluid

190

1.20

0.40

1.3

mmol/l

7.0

6.7

0.12

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

121

907

0.92

0.40

1.3

u/ml

2.0

1.2

0.36

475

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

592

1.10

0.40

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

244

1583

1.06

0.38

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

294

1.15

0.38

1.1

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

279

2023

0.95

0.37

1.8

pmol/l

200.5

195.5

0.36

249

1889

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

107

674

1.09

0.37

1.3

g/l

1.6

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

324

2123

1.05

0.37

1.7

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.47

0.36

1.8

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

302

1977

1.05

0.36

1.7

1.6

g/l

0.7

0.8

2.23

232

1483

(3015171) Extractable nuclear Ab [Units/volume] in Serum

784

5234

1.03

0.36

1.2

u/ml

0.9

0.7

0.20

484

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

114

851

0.92

0.36

1.4

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

108

683

1.09

0.35

1.1

iu/ml

16.0

10.5

0.87

133

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

280

0.86

0.35

1.9

1.5

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.38

0.35

1.0

u/l

206.3

609.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

316

1.13

0.34

1.2

1.1

—

(1002224) Polysomnography panel

592

4210

0.97

0.34

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

526

0.90

0.34

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

123

0.78

0.34

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

223

1621

0.95

0.34

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

2587

17532

1.02

0.34

1.3

titre

473.4

576.0

2.38

556

3951

(44806071)

153

0.81

0.34

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.33

0.34

1.1

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.33

0.34

2.3

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.33

0.34

1.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

366

0.88

0.33

1.1

—

(3015183) Erythrocyte sedimentation rate

424

0.89

0.33

1.8

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

230

1668

0.95

0.33

1.2

u/ml

57.2

55.5

0.03

121

(3047181) Lactate [Moles/volume] in Blood

628

4188

1.03

0.32

5.1

5.7

mmol/l

1.3

0.04

547

3713

(3011335) Digoxin [Mass/volume] in Serum or Plasma

144

1.19

0.32

2.7

2.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

248

0.86

0.32

1.0

u/ml

0.9

0.03

117

(3014148) Varicella zoster virus Ab [Titer] in Serum

167

1080

1.06

0.32

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

189

1.16

0.31

1.2

1.9

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

509

1.09

0.31

2.4

2.2

umol/l

61.5

57.1

0.57

393

(3036071) Salmonella sp Ab [Titer] in Serum

319

1.12

0.31

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

113

1.22

0.31

1.2

1.3

10.3

23.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

248

1625

1.05

0.31

1.3

1.2

nmol/l

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.30

0.30

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

194

1263

1.06

0.30

1.6

u/ml

26.7

25.4

0.13

282

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.71

0.29

2.8

1.9

—

(4094501)

573

4061

0.97

0.29

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

120

0.80

0.29

1.4

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

612

1.08

0.28

1.3

—

(4146454)

262

1882

0.96

0.28

2.6

2.7

—

(3022689) Creatine [Moles/volume] in Urine

454

1.09

0.27

1.6

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

432

0.91

0.27

1.1

miu/ml

1640.6

1635.3

0.01

432

(3033923) Metanephrine [Moles/time] in 24 hour Urine

316

1.11

0.27

1.0

1.1

umol/24h

0.6

0.7

0.14

138

(3000330) Specific gravity of Urine by Test strip

1122

7568

1.02

0.27

4.2

3.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

147

1.17

0.27

1.4

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

521

1.08

0.27

2.9

3.0

umol/l

27.2

28.4

0.50

393

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.67

0.26

1.0

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

180

1.15

0.26

1.2

1.5

mu/l

438.6

815.2

1.00

172

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

154

1003

1.06

0.26

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

252

1663

1.04

0.25

1.2

u/ml

3.6

3.9

0.08

583

(3047007) Chlamydophila sp Ab [Presence] in Serum

232

1529

1.04

0.25

1.3

1.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.19

0.25

1.2

1.3

mg/l

1.9

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

142

924

1.06

0.25

1.1

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

412

2923

0.97

0.24

1.2

u/ml

0.6

16.0

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

181

1.14

0.24

1.2

1.5

73.6

71.8

0.30

173

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

136

1.16

0.24

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

215

1543

0.96

0.23

1.1

118.8

118.4

0.05

191

1379

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.32

0.23

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

313

1.10

0.23

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

612

0.93

0.23

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

142

927

1.05

0.23

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

142

927

1.05

0.23

1.1

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.76

0.23

4.9

7.5

—

(3010937) Rubella virus Ab [Presence] in Serum

1.27

0.23

1.2

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

119

773

1.06

0.23

1.5

1.4

4.4

4.06

166

(4306422)

223

1597

0.96

0.22

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.73

0.22

1.0

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

355

0.91

0.22

1.4

1.2

114.9

113.5

0.15

311

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.20

0.22

2.9

2.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

297

0.90

0.22

1.1

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

261

0.90

0.22

1.2

1.3

—

(3006462) Nitrate [Presence] in Urine

107

694

1.06

0.22

3.7

3.3

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.22

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

397

0.92

0.22

1.5

1.6

ug/l

9.3

9.1

0.16

397

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

308

2050

1.03

0.22

1.5

62.2

59.0

0.69

188

1302

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3004775) Volume in Urine collected for unspecified duration

191

1260

1.04

0.21

2.5

2.3

706.6

661.0

0.73

131

856

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

368

1.08

0.21

1.2

1.3

nmol/l

123.9

142.8

0.43

254

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

355

1.09

0.21

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

142

931

1.05

0.20

1.1

1.2

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.20

0.20

1.9

1.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

502

1.07

0.20

1.3

61.3

57.0

0.46

435

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

162

1066

1.05

0.20

1.3

titre

444.0

405.8

0.09

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.81

0.20

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

142

932

1.05

0.20

1.1

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

252

0.90

0.20

2.1

1.6

mmol/l

1.2

0.93

243

(3002621) Streptococcal DNAse B [Units/volume] in Serum

106

1.17

0.20

1.1

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

588

4132

0.98

0.19

1.8

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

142

933

1.05

0.19

1.1

1.2

—

(3022621) pH of Urine by Test strip

1348

9396

0.99

0.19

3.2

3.1

—

(3038515) Glucose [Moles/volume] in Venous blood

482

3241

1.02

0.18

3.9

3.3

mmol/l

7.4

7.7

1.95

471

3178

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

386

0.93

0.18

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

386

0.93

0.18

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

386

0.93

0.18

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

386

0.93

0.18

1.0

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

165

1181

0.96

0.18

1.1

97.9

94.8

0.78

154

1104

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

156

1030

1.04

0.18

1.3

titre

77.5

60.6

0.32

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.22

0.18

5.3

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

120

865

0.95

0.18

1.4

1.3

u/l

38.5

37.0

0.19

104

639

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

314

0.92

0.17

1.2

1.3

mg/l

1.1

21.9

0.71

237

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.15

0.17

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.15

0.17

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

140

1.13

0.17

1.0

1.1

umol/24h

1.4

1.7

1.64

140

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

392

1.07

0.17

1.6

ug/l

0.5

0.4

0.58

247

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.12

0.17

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

702

0.95

0.17

1.7

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

147

1.12

0.17

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

249

0.91

0.17

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.83

0.16

1.0

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

460

1.06

0.16

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.17

0.16

1.6

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

447

0.94

0.16

1.0

1.1

100.9

98.0

0.18

343

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

243

1623

1.03

0.16

1.2

u/ml

3.3

4.0

0.55

110

731

(3042951) Complement C1q Ab [Units/volume] in Serum

0.78

0.16

1.2

—

17.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

115

1.14

0.16

1.1

u/ml

0.0

0.8

1.13

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

133

951

0.96

0.15

2.2

1.6

u/l

859.3

2394.7

1.36

351

(3016330) Potassium [Moles/time] in 24 hour Urine

188

1.10

0.15

1.2

—

88.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

308

1.07

0.15

1.4

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

111

0.87

0.15

1.8

1.4

39.1

47.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.21

0.15

2.0

2.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.18

0.14

1.2

1.3

umol/24h

351.8

308.7

0.31

(3003740) Influenza virus B Ag [Presence] in Specimen

163

1084

1.03

0.14

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

389

1.06

0.14

1.4

1.2

24.5

23.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

381

0.94

0.14

1.3

1.2

g/l

0.3

0.06

311

(3002523) Influenza virus A Ag [Presence] in Specimen

163

1085

1.03

0.14

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.82

0.14

1.3

1.2

—

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

180

1201

1.03

0.14

1.1

—

23.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

189

0.91

0.13

3.2

2.8

u/field

0.5

0.6

0.12

189

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

640

4337

1.02

0.13

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

113

748

1.04

0.13

1.0

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

110

728

1.04

0.13

1.2

u/l

178.3

337.2

2.28

675

(3017569) Oxygen content in Arterial blood

102

675

1.04

0.12

1.9

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

358

1.06

0.12

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

628

1.04

0.12

1.1

ratio

1.1

0.03

213

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

144

1.10

0.12

1.0

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

205

1375

1.03

0.12

1.1

iu/ml

4.0

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

146

1035

0.97

0.12

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

548

3824

0.99

0.11

2.6

2.3

ug/min

126.6

107.8

0.38

311

2192

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

657

0.96

0.11

6.0

4.5

u/ml

7370.9

510.4

0.44

104

(3008037) Lactate [Moles/volume] in Venous blood

501

3400

1.01

0.10

3.9

3.2

mmol/l

1.5

1.6

1.37

490

3330

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.15

0.10

1.2

g/l

0.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1040

7213

0.99

0.09

1.2

iu/ml

120.6

136.7

0.68

334

2741

(4027681)

535

0.96

0.09

1.2

—

(3000285) Sodium [Moles/volume] in Blood

227

0.94

0.09

1.2

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.06

0.08

1.0

mg/l

0.1

0.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

532

1.03

0.08

1.0

1.1

u/l

1.2

1.0

0.88

260

(3044009) aPTT.lupus sensitive (LA screen)

100

1.10

0.08

1.1

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

673

0.97

0.08

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

561

0.97

0.08

1.3

1.2

63.1

54.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

411

1.04

0.08

1.2

1.3

28.6

36.9

0.99

269

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.81

0.07

12.2

8.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

525

0.97

0.07

1.5

1.8

umol/l

78.6

115.5

1.27

276

(3000034) Microalbumin [Mass/volume] in Urine

208

1408

1.02

0.07

3.7

3.0

mg/l

49.6

43.7

0.16

145

1005

(3014599) Egg white IgE Ab [Units/volume] in Serum

427

0.97

0.07

1.0

u/ml

0.6

0.5

—

104

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.89

0.07

1.6

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.86

0.07

1.3

1.0

mmol/l

7.5

8.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

343

0.96

0.06

1.7

1.6

ng/l

153.8

117.4

0.70

343

(40762814) Titanium [Mass/volume] in Blood

352

1.04

0.06

2.1

2.3

ug/l

2.9

3.6

1.07

126

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

106

713

1.02

0.06

1.1

mg/l

394.5

289.2

0.73

637

(3034092) Cytoplasmic Ig cells/100 cells in Blood

161

0.94

0.06

9.5

10.1

—

(3020491) Glucose [Moles/volume] in Blood

145

980

1.02

0.06

2.2

2.0

mmol/l

7.3

7.1

0.66

105

665

(46235168) Fasting glucose [Moles/volume] in Blood

129

1.07

0.05

10.9

1.8

mmol/l

7.5

7.2

0.13

(3032743) Legionella sp IgG Ab [Presence] in Serum

102

1.08

0.05

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

341

0.97

0.05

1.0

u/ml

0.1

0.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

423

2887

1.01

0.05

1.5

1.8

iu/l

6.8

15.2

0.50

101

994

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

498

3450

0.99

0.05

1.3

—

(4133840)

305

0.97

0.04

1.3

1.2

—

(4268621)

161

1094

1.01

0.04

2.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.92

0.03

1.1

—

(4211845)

111

753

1.01

0.03

3.7

3.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

670

0.99

0.03

1.6

1.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

221

1508

1.01

0.03

1.4

1.5

22.0

28.5

2.25

126

942

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

288

1968

1.01

0.03

1.2

—

(3019174) dRVVT (LA screen)

104

1.06

0.03

1.1

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

104

1.06

0.03

1.1

—

(44813793)

124

862

0.99

0.02

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

378

0.98

0.02

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

201

1374

1.01

0.02

1.2

1.3

—

41.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

108

750

0.99

0.01

1.1

mg/l

65.8

42.3

0.63

635

(3038177) Helicobacter pylori Ab [Presence] in Serum

266

1838

1.00

0.01

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

297

1.02

0.01

3.4

2.9

mg/l

8.7

6.8

1.20

242

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

167

1156

0.99

0.01

1.1

au/ml

131.3

52.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

156

0.97

0.01

1.8

1.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.95

0.01

1.1

1.0

—

(3019977) pH of Arterial blood

115

786

1.01

0.01

1.9

2.4

7.4

1.22

269

(3028717) Thiamine [Mass/volume] in Blood

114

0.97

0.00

1.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.00

0.00

1.4

1.5

mmol/l

19.9

23.7

—

(3050794) Legionella sp Ab [Presence] in Serum

123

1.01

0.00

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

127

0.97

0.00

1.2

1.1

u/ml

79.9

58.9

0.50

121

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

322

1.00

0.00

2.1

2.6

mmol/l

6.8

7.8

1.57

198

(3037556) Urate [Mass/volume] in Serum or Plasma

498

0.99

0.00

1.6

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

214

1.00

0.00

1.5

1.3

54.8

47.4

0.33

(3010144) Erythrocytes [#/volume] in Synovial fluid

226

1553

1.00

0.00

1.3

1.4

e6/l

90474.4

139893.9

0.63

151

1061

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

126

0.98

0.00

1.1

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

122

1.01

0.00

1.1

1.0

—

(3034426) Prothrombin time (PT)

365

1.00

0.00

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.97

0.00

1.0

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

101

1.02

0.00

2.0

2.2

mmol/l

1.6

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

642

1.00

0.00

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

516

1.00

0.00

1.1

ng/l

751.6

764.0

0.01

122

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

132

907

1.00

0.00

1.1

1.0

mg/l

306.8

288.4

2.01

110

816

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.96

0.00

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.92

0.00

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.86

0.00

1.4

1.2

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

22.9

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC – Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

GWS hits: 100

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers) (C3_BASAL_CELL_CARCINOMA_INCLAVO_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints